Gene Map Search - 'familial hypercholesterolemia '
Downloaded:	Jun 06, 2023
Copyright (c) 1966-2023 Johns Hopkins University OMIM, data are provided for research purposes only.

Cytogenetic location	Genomic coordinates (From NCBI/GRCh38)	Gene/Locus	Gene/Locus name	Gene/Locus MIM number	Approved Symbol	Entrez Gene ID	Ensembl Gene ID	Comments	Phenotype	Phenotype MIM number	Inheritance	Pheno map key	Mouse Gene (from MGI)
1p36.23	1:7784291-7845177	PER3, FASPS3	Period circadian regulator 3	603427	PER3	8863	ENSG00000049246,ENST00000377532;;;ENST00000377532	mutation identified in 1 FASPS3 family	?Advanced sleep phase syndrome, familial, 3	616882	Autosomal dominant	3	Per3
1p36.22	1:11845709-11847783	NPPA, PND, ANP, ATFB6, ATRST2	Natriuretic peptide precursor A	108780	NPPA	4878	ENSG00000175206,ENST00000376480;;;ENST00000376480		Atrial fibrillation, familial, 6	612201	Autosomal dominant	3	Nppa
1p36.22	1:11845709-11847783	NPPA, PND, ANP, ATFB6, ATRST2	Natriuretic peptide precursor A	108780	NPPA	4878	ENSG00000175206,ENST00000376480;;;ENST00000376480		Atrial standstill 2	615745	Autosomal recessive	3	Nppa
1p36.13	1:20028408-20091911	PLA2G5, FRFB	Phospholipase A2, group V	601192	PLA2G5	5322	ENSG00000127472,ENST00000375108;;;ENST00000375108		[Fleck retina, familial benign]	228980	Autosomal recessive	3	Pla2g5
1p36.12-p35.1	1:20100001-34300000	BFIS4, BFIC4	Seizures, benign familial infantile, 4	612627		100271922		between D1S2864 and D1S2830	Seizures, benign familial infantile, 4	612627		2	
1p36.11	1:25543606-25590400	LDLRAP1, ARH, FHCB2, FHCB1, FHCL4	Low density lipoprotein receptor adaptor protein 1	605747	LDLRAP1	26119	ENSG00000157978,ENST00000374338;;;ENST00000374338		Hypercholesterolemia, familial, 4	603813	Autosomal recessive	3	Ldlrap1
1p33	1:47416285-47418052	FOXE3, FKHL12, ASMD, CTRCT34, ASGD2, AAT11	Forkhead box E3	601094	FOXE3	2301	ENSG00000186790,ENST00000335071;;;ENST00000335071		Anterior segment dysgenesis 2, multiple subtypes	610256	Autosomal recessive	3	Foxe3
1p33	1:47416285-47418052	FOXE3, FKHL12, ASMD, CTRCT34, ASGD2, AAT11	Forkhead box E3	601094	FOXE3	2301	ENSG00000186790,ENST00000335071;;;ENST00000335071		Cataract 34, multiple types	612968		3	Foxe3
1p33	1:47416285-47418052	FOXE3, FKHL12, ASMD, CTRCT34, ASGD2, AAT11	Forkhead box E3	601094	FOXE3	2301	ENSG00000186790,ENST00000335071;;;ENST00000335071		{Aortic aneurysm, familial thoracic 11, susceptibility to}	617349	Autosomal dominant	3	Foxe3
1p32.3	1:55039548-55064852	PCSK9, NARC1, HCHOLA3, FH3, LDLCQ1, FHCL3	Proprotein convertase, subtilisin/kexin-type, 9	607786	PCSK9	255738	ENSG00000169174,ENST00000302118;;;ENST00000302118		Hypercholesterolemia, familial, 3	603776	Autosomal dominant	3	Pcsk9
1p32.3	1:55039548-55064852	PCSK9, NARC1, HCHOLA3, FH3, LDLCQ1, FHCL3	Proprotein convertase, subtilisin/kexin-type, 9	607786	PCSK9	255738	ENSG00000169174,ENST00000302118;;;ENST00000302118		{Low density lipoprotein cholesterol level QTL 1}	603776	Autosomal dominant	3	Pcsk9
1p31.3	1:62597520-62606313	ANGPTL3, ANGPT5, FHBL2	Angiopoietin-like 3	604774	ANGPTL3	27329	ENSG00000132855,ENST00000371129;;;ENST00000371129		Hypobetalipoproteinemia, familial, 2	605019	Autosomal recessive	3	Angptl3
1p13.2	1:112911847-112956196	SLC16A1, MCT1, HHF7, MCT1D	Solute carrier family 16 (monocarboxylic acid transporters), member 1	600682	SLC16A1	6566	ENSG00000155380,ENST00000369626;;;ENST00000369626		Erythrocyte lactate transporter defect	245340	Autosomal dominant	3	Slc16a1
1p13.2	1:112911847-112956196	SLC16A1, MCT1, HHF7, MCT1D	Solute carrier family 16 (monocarboxylic acid transporters), member 1	600682	SLC16A1	6566	ENSG00000155380,ENST00000369626;;;ENST00000369626		Hyperinsulinemic hypoglycemia, familial, 7	610021	Autosomal dominant	3	Slc16a1
1p13.2	1:112911847-112956196	SLC16A1, MCT1, HHF7, MCT1D	Solute carrier family 16 (monocarboxylic acid transporters), member 1	600682	SLC16A1	6566	ENSG00000155380,ENST00000369626;;;ENST00000369626		Monocarboxylate transporter 1 deficiency	616095	Autosomal dominant; Autosomal recessive	3	Slc16a1
1q21.2	1:147756199-147773351	GJA5, CX40, ATFB11	Gap junction protein, alpha-5, 40kD (connexin 40)	121013	GJA5	2702	ENSG00000265107,ENST00000579774;;;ENST00000579774		Atrial fibrillation, familial, 11	614049	Autosomal dominant	3	Gja5
1q21.2	1:147756199-147773351	GJA5, CX40, ATFB11	Gap junction protein, alpha-5, 40kD (connexin 40)	121013	GJA5	2702	ENSG00000265107,ENST00000579774;;;ENST00000579774		Atrial standstill, digenic (GJA5/SCN5A)	108770	Autosomal dominant	3	Gja5
1q21.2	1:149782694-149800609	FCGR1A, IGFR1, CD64	Fc fragment of IgG receptor Ia	146760	FCGR1A	2209	ENSG00000150337,ENST00000369168;;;ENST00000369168		[IgG receptor I, phagocytic, familial deficiency of]			3	Fcgr1
1q22	1:156082573-156140081	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS	Lamin A/C	150330	LMNA	4000	ENSG00000160789,ENST00000368300;;;ENST00000368300		Cardiomyopathy, dilated, 1A	115200	Autosomal dominant	3	Lmna
1q22	1:156082573-156140081	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS	Lamin A/C	150330	LMNA	4000	ENSG00000160789,ENST00000368300;;;ENST00000368300		Charcot-Marie-Tooth disease, type 2B1	605588	Autosomal recessive	3	Lmna
1q22	1:156082573-156140081	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS	Lamin A/C	150330	LMNA	4000	ENSG00000160789,ENST00000368300;;;ENST00000368300		Emery-Dreifuss muscular dystrophy 2, autosomal dominant	181350	Autosomal dominant	3	Lmna
1q22	1:156082573-156140081	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS	Lamin A/C	150330	LMNA	4000	ENSG00000160789,ENST00000368300;;;ENST00000368300		Emery-Dreifuss muscular dystrophy 3, autosomal recessive	616516	Autosomal recessive	3	Lmna
1q22	1:156082573-156140081	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS	Lamin A/C	150330	LMNA	4000	ENSG00000160789,ENST00000368300;;;ENST00000368300		Heart-hand syndrome, Slovenian type	610140	Autosomal dominant	3	Lmna
1q22	1:156082573-156140081	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS	Lamin A/C	150330	LMNA	4000	ENSG00000160789,ENST00000368300;;;ENST00000368300		Hutchinson-Gilford progeria	176670	Autosomal dominant	3	Lmna
1q22	1:156082573-156140081	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS	Lamin A/C	150330	LMNA	4000	ENSG00000160789,ENST00000368300;;;ENST00000368300		Lipodystrophy, familial partial, type 2	151660	Autosomal dominant	3	Lmna
1q22	1:156082573-156140081	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS	Lamin A/C	150330	LMNA	4000	ENSG00000160789,ENST00000368300;;;ENST00000368300		Malouf syndrome	212112	Autosomal dominant	3	Lmna
1q22	1:156082573-156140081	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS	Lamin A/C	150330	LMNA	4000	ENSG00000160789,ENST00000368300;;;ENST00000368300		Mandibuloacral dysplasia	248370	Autosomal recessive	3	Lmna
1q22	1:156082573-156140081	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS	Lamin A/C	150330	LMNA	4000	ENSG00000160789,ENST00000368300;;;ENST00000368300		Muscular dystrophy, congenital	613205	Autosomal dominant	3	Lmna
1q22	1:156082573-156140081	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS	Lamin A/C	150330	LMNA	4000	ENSG00000160789,ENST00000368300;;;ENST00000368300		Restrictive dermopathy 2	619793		3	Lmna
1q23.2	1:160115759-160143591	ATP1A2, FHM2, MHP2, FARIMPD, DEE98	ATPase, Na+K+ transporting, alpha-2 polypeptide	182340	ATP1A2	477	ENSG00000018625,ENST00000361216;;;ENST00000361216		Alternating hemiplegia of childhood 1	104290	Autosomal dominant	3	Atp1a2
1q23.2	1:160115759-160143591	ATP1A2, FHM2, MHP2, FARIMPD, DEE98	ATPase, Na+K+ transporting, alpha-2 polypeptide	182340	ATP1A2	477	ENSG00000018625,ENST00000361216;;;ENST00000361216		Developmental and epileptic encephalopathy 98	619605	Autosomal dominant	3	Atp1a2
1q23.2	1:160115759-160143591	ATP1A2, FHM2, MHP2, FARIMPD, DEE98	ATPase, Na+K+ transporting, alpha-2 polypeptide	182340	ATP1A2	477	ENSG00000018625,ENST00000361216;;;ENST00000361216		Fetal akinesia, respiratory insufficiency, microcephaly, polymicrogyria, and dysmorphic facies	619602	Autosomal recessive	3	Atp1a2
1q23.2	1:160115759-160143591	ATP1A2, FHM2, MHP2, FARIMPD, DEE98	ATPase, Na+K+ transporting, alpha-2 polypeptide	182340	ATP1A2	477	ENSG00000018625,ENST00000361216;;;ENST00000361216		Migraine, familial basilar	602481	Autosomal dominant	3	Atp1a2
1q23.2	1:160115759-160143591	ATP1A2, FHM2, MHP2, FARIMPD, DEE98	ATPase, Na+K+ transporting, alpha-2 polypeptide	182340	ATP1A2	477	ENSG00000018625,ENST00000361216;;;ENST00000361216		Migraine, familial hemiplegic, 2	602481	Autosomal dominant	3	Atp1a2
1q23.2	1:160343383-160358949	NCSTN	Nicastrin	605254	NCSTN	23385	ENSG00000162736,ENST00000294785;;;ENST00000294785		Acne inversa, familial, 1	142690	Autosomal dominant	3	Ncstn
1q23.3	1:161039251-161045977	USF1, HYPLIP1	Upstream transcription factor 1	191523	USF1	7391	ENSG00000158773,ENST00000368021;;;ENST00000368021		{Hyperlipidemia, familial combined, susceptibility to}	602491		3	Usf1
1q23.3	1:161222292-161223628	APOA2	Apolipoprotein A-II	107670	APOA2	336	ENSG00000158874,ENST00000367990;;;ENST00000367990		Apolipoprotein A-II deficiency			3	Apoa2
1q23.3	1:161222292-161223628	APOA2	Apolipoprotein A-II	107670	APOA2	336	ENSG00000158874,ENST00000367990;;;ENST00000367990		{Hypercholesterolemia, familial, modifier of}	143890	Autosomal dominant; Autosomal recessive	3	Apoa2
1q31	1:185800001-198700000	MGR6, FHM3	Migraine, several forms	607516		317773			{Migraine with or without aura, susceptibility to, 6}	607516	Autosomal dominant	2	
1q31	1:185800001-198700000	MGR6, FHM3	Migraine, several forms	607516		317773			{Migraine, familial hemiplegic, 4}	607516	Autosomal dominant	2	
1q31.2	1:193122031-193254815	CDC73, HRPT2, C1orf28	Cell division cycle 73	607393	CDC73	79577	ENSG00000134371,ENST00000367435;;;ENST00000367435		Hyperparathyroidism, familial primary	145000	Autosomal dominant	3	Cdc73
1q31.2	1:193122031-193254815	CDC73, HRPT2, C1orf28	Cell division cycle 73	607393	CDC73	79577	ENSG00000134371,ENST00000367435;;;ENST00000367435		Hyperparathyroidism-jaw tumor syndrome	145001	Autosomal dominant	3	Cdc73
1q31.2	1:193122031-193254815	CDC73, HRPT2, C1orf28	Cell division cycle 73	607393	CDC73	79577	ENSG00000134371,ENST00000367435;;;ENST00000367435		Parathyroid adenoma with cystic changes	145001	Autosomal dominant	3	Cdc73
1q31.2	1:193122031-193254815	CDC73, HRPT2, C1orf28	Cell division cycle 73	607393	CDC73	79577	ENSG00000134371,ENST00000367435;;;ENST00000367435		Parathyroid carcinoma	608266		3	Cdc73
1q32	1:198700001-214400000	PFHB2	Progressive familial heart block, type II	140400		105463127		between D1S70 and D1S505	Progressive familial heart block, type II	140400	Autosomal dominant	2	
1q32.1	1:201359014-201377680	TNNT2, CMH2, CMD1D, RCM3, LVNC6	Troponin-T2, cardiac	191045	TNNT2	7139	ENSG00000118194,ENST00000656932;;;ENST00000656932		Cardiomyopathy, dilated, 1D	601494	Autosomal dominant	3	Tnnt2
1q32.1	1:201359014-201377680	TNNT2, CMH2, CMD1D, RCM3, LVNC6	Troponin-T2, cardiac	191045	TNNT2	7139	ENSG00000118194,ENST00000656932;;;ENST00000656932		Cardiomyopathy, familial restrictive, 3	612422	Autosomal dominant	3	Tnnt2
1q32.1	1:201359014-201377680	TNNT2, CMH2, CMD1D, RCM3, LVNC6	Troponin-T2, cardiac	191045	TNNT2	7139	ENSG00000118194,ENST00000656932;;;ENST00000656932		Cardiomyopathy, hypertrophic, 2	115195	Autosomal dominant	3	Tnnt2
1q32.1	1:201359014-201377680	TNNT2, CMH2, CMD1D, RCM3, LVNC6	Troponin-T2, cardiac	191045	TNNT2	7139	ENSG00000118194,ENST00000656932;;;ENST00000656932		Left ventricular noncompaction 6	601494	Autosomal dominant	3	Tnnt2
1q32.1	1:205042949-205078289	CNTN2, TAX, TAX1, FAME5	Contactin 2 (transiently-expressed axonal glycoprotein)	190197	CNTN2	6900	ENSG00000184144,ENST00000331830;;;ENST00000331830	1 family identified with mutation	?Epilepsy, myoclonic, familial adult, 5	615400	Autosomal recessive	3	Cntn2
1q42.2	1:231363756-231422287	EGLN1, PHD2, HIFPH2, C1orf12, ZMYND6, SM20, ECYT3, HALAH	egl-9 family hypoxia inducible factor 1	606425	EGLN1	54583	ENSG00000135766,ENST00000366641;;;ENST00000366641		Erythrocytosis, familial, 3	609820	Autosomal dominant	3	Egln1
1q42.2	1:231363756-231422287	EGLN1, PHD2, HIFPH2, C1orf12, ZMYND6, SM20, ECYT3, HALAH	egl-9 family hypoxia inducible factor 1	606425	EGLN1	54583	ENSG00000135766,ENST00000366641;;;ENST00000366641		[Hemoglobin, high altitude adaptation]	609070	Autosomal dominant	3	Egln1
1q44	1:247416077-247448817	NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1, DFNA34, KEFH	NLR family, pyrin domain containing 3	606416	NLRP3	114548	ENSG00000162711,ENST00000336119;;;ENST00000336119		CINCA syndrome	607115	Autosomal dominant	3	Nlrp3
1q44	1:247416077-247448817	NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1, DFNA34, KEFH	NLR family, pyrin domain containing 3	606416	NLRP3	114548	ENSG00000162711,ENST00000336119;;;ENST00000336119		Deafness, autosomal dominant 34, with or without inflammation	617772	Autosomal dominant	3	Nlrp3
1q44	1:247416077-247448817	NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1, DFNA34, KEFH	NLR family, pyrin domain containing 3	606416	NLRP3	114548	ENSG00000162711,ENST00000336119;;;ENST00000336119		Familial cold inflammatory syndrome 1	120100	Autosomal dominant	3	Nlrp3
1q44	1:247416077-247448817	NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1, DFNA34, KEFH	NLR family, pyrin domain containing 3	606416	NLRP3	114548	ENSG00000162711,ENST00000336119;;;ENST00000336119		Keratoendothelitis fugax hereditaria	148200	Autosomal dominant	3	Nlrp3
1q44	1:247416077-247448817	NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1, DFNA34, KEFH	NLR family, pyrin domain containing 3	606416	NLRP3	114548	ENSG00000162711,ENST00000336119;;;ENST00000336119		Muckle-Wells syndrome	191900	Autosomal dominant	3	Nlrp3
2p24.1	2:21001429-21044073	APOB, FLDB, LDLCQ4, FCHL2	Apolipoprotein B (including Ag(x) antigen)	107730	APOB	338	ENSG00000084674,ENST00000233242;;;ENST00000233242	1 gene for liver apo-B100 and gut apo-B48; Ag linked	Hypercholesterolemia, familial, 2	144010	Autosomal dominant	3	Apob
2p24.1	2:21001429-21044073	APOB, FLDB, LDLCQ4, FCHL2	Apolipoprotein B (including Ag(x) antigen)	107730	APOB	338	ENSG00000084674,ENST00000233242;;;ENST00000233242	1 gene for liver apo-B100 and gut apo-B48; Ag linked	Hypobetalipoproteinemia	615558	Autosomal recessive	3	Apob
2p22.3-p21	2:31800001-47500000	CANDF1, CMCT	Candidiasis, familial, 1	114580		117084		between D2S367 and D2S2240	Candidiasis, familial, 1, autosomal dominant	114580	Autosomal dominant	2	
2p22.3	2:32224449-32265743	NLRC4, CARD12, CLAN, IPAF, AIFEC, FCAS4	NLR family, caspase recruitment domain-containing 4	606831	NLRC4	58484	ENSG00000091106,ENST00000402280;;;ENST00000402280	mutation identified in 1 FCAS4 family	?Familial cold autoinflammatory syndrome 4	616115	Autosomal dominant	3	Nlrc4
2p22.3	2:32224449-32265743	NLRC4, CARD12, CLAN, IPAF, AIFEC, FCAS4	NLR family, caspase recruitment domain-containing 4	606831	NLRC4	58484	ENSG00000091106,ENST00000402280;;;ENST00000402280	mutation identified in 1 FCAS4 family	Autoinflammation with infantile enterocolitis	616050	Autosomal dominant	3	Nlrc4
2p22.1-p21	2:38300001-47500000	HNFJ3	Hyperuricemic nephropathy, familial juvenile, 3	614227		100689490		between rs372139 and rs896986	Hyperuricemic nephropathy, familial juvenile, 3	614227	Autosomal dominant	2	
2p21	2:46297407-46386697	EPAS1, MOP2, HIF2A, ECYT4	Endothelial PAS domain protein 1	603349	EPAS1	2034	ENSG00000116016,ENST00000263734;;;ENST00000263734		Erythrocytosis, familial, 4	611783	Autosomal dominant	3	Epas1
2p16.3	2:47783145-47810101	MSH6, GTBP, LYNCH5, MMRCS3	mutS homolog 6	600678	MSH6	2956	ENSG00000116062,ENST00000234420;;;ENST00000234420	0.5 Mb from MSH2	Lynch syndrome 5	614350	Autosomal dominant	3	Msh6
2p16.3	2:47783145-47810101	MSH6, GTBP, LYNCH5, MMRCS3	mutS homolog 6	600678	MSH6	2956	ENSG00000116062,ENST00000234420;;;ENST00000234420	0.5 Mb from MSH2	Mismatch repair cancer syndrome 3	619097	Autosomal recessive	3	Msh6
2p16.3	2:47783145-47810101	MSH6, GTBP, LYNCH5, MMRCS3	mutS homolog 6	600678	MSH6	2956	ENSG00000116062,ENST00000234420;;;ENST00000234420	0.5 Mb from MSH2	{Endometrial cancer, familial}	608089	Autosomal dominant; Somatic mutation	3	Msh6
2p11.2	2:86784605-86808396	CD8A	CD8 antigen, alpha polypeptide  (p32)	186910	CD8A	925	ENSG00000153563,ENST00000283635;;;ENST00000283635	distal to IGK	CD8 deficiency, familial	608957	Autosomal recessive	3	Cd8a
2q11.2	2:96184859-96208827	STARD7, GTT1, FAME2	START domain-containing protein 4	616712	STARD7	56910	ENSG00000084090,ENST00000337288;;;ENST00000337288		Epilepsy, familial adult myoclonic, 2	607876	Autosomal dominant	3	Stard7
2q24.3	2:165087526-165204050	SCN3A, FFEVF4, DEE62	Sodium voltage-gated channel, alpha subunit 3	182391	SCN3A	6328	ENSG00000153253,ENST00000283254;;;ENST00000283254		Developmental and epileptic encephalopathy 62	617938	Autosomal dominant	3	Scn3a
2q24.3	2:165087526-165204050	SCN3A, FFEVF4, DEE62	Sodium voltage-gated channel, alpha subunit 3	182391	SCN3A	6328	ENSG00000153253,ENST00000283254;;;ENST00000283254		Epilepsy, familial focal, with variable foci 4	617935	Autosomal dominant	3	Scn3a
2q24.3	2:165239414-165392304	SCN2A, SCN2A1, BFIC3, DEE11, BFIS3, BFNIS, EA9	Sodium voltage-gated channel, alpha subunit 2	182390	SCN2A	6326	ENSG00000136531,ENST00000375437;;;ENST00000375437	4 related genes on chr.2	Developmental and epileptic encephalopathy 11	613721	Autosomal dominant	3	Scn2a
2q24.3	2:165239414-165392304	SCN2A, SCN2A1, BFIC3, DEE11, BFIS3, BFNIS, EA9	Sodium voltage-gated channel, alpha subunit 2	182390	SCN2A	6326	ENSG00000136531,ENST00000375437;;;ENST00000375437	4 related genes on chr.2	Episodic ataxia, type 9	618924	Autosomal dominant	3	Scn2a
2q24.3	2:165239414-165392304	SCN2A, SCN2A1, BFIC3, DEE11, BFIS3, BFNIS, EA9	Sodium voltage-gated channel, alpha subunit 2	182390	SCN2A	6326	ENSG00000136531,ENST00000375437;;;ENST00000375437	4 related genes on chr.2	Seizures, benign familial infantile, 3	607745	Autosomal dominant	3	Scn2a
2q24.3	2:165747588-165794692	GALNT3, HHS, HFTC1	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3	601756	GALNT3	2591	ENSG00000115339,ENST00000392701;;;ENST00000392701		Tumoral calcinosis, hyperphosphatemic, familial, 1	211900	Autosomal recessive	3	Galnt3
2q24.3	2:165984641-166149161	SCN1A, GEFSP2, SMEI, FEB3A, DEE6A, DRVT, FHM3, DEE6B	Sodium voltage-gated channel, alpha subunit 1	182389	SCN1A	6323	ENSG00000144285,ENST00000674923;;;ENST00000674923		Developmental and epileptic encephalopathy 6B, non-Dravet	619317	Autosomal dominant	3	Scn1a
2q24.3	2:165984641-166149161	SCN1A, GEFSP2, SMEI, FEB3A, DEE6A, DRVT, FHM3, DEE6B	Sodium voltage-gated channel, alpha subunit 1	182389	SCN1A	6323	ENSG00000144285,ENST00000674923;;;ENST00000674923		Dravet syndrome	607208	Autosomal dominant	3	Scn1a
2q24.3	2:165984641-166149161	SCN1A, GEFSP2, SMEI, FEB3A, DEE6A, DRVT, FHM3, DEE6B	Sodium voltage-gated channel, alpha subunit 1	182389	SCN1A	6323	ENSG00000144285,ENST00000674923;;;ENST00000674923		Febrile seizures, familial, 3A	604403	Autosomal dominant	3	Scn1a
2q24.3	2:165984641-166149161	SCN1A, GEFSP2, SMEI, FEB3A, DEE6A, DRVT, FHM3, DEE6B	Sodium voltage-gated channel, alpha subunit 1	182389	SCN1A	6323	ENSG00000144285,ENST00000674923;;;ENST00000674923		Generalized epilepsy with febrile seizures plus, type 2	604403	Autosomal dominant	3	Scn1a
2q24.3	2:165984641-166149161	SCN1A, GEFSP2, SMEI, FEB3A, DEE6A, DRVT, FHM3, DEE6B	Sodium voltage-gated channel, alpha subunit 1	182389	SCN1A	6323	ENSG00000144285,ENST00000674923;;;ENST00000674923		Migraine, familial hemiplegic, 3	609634	Autosomal dominant	3	Scn1a
2q31.1	2:168915390-169031324	ABCB11, BSEP, SPGP, PFIC2, BRIC2	ATP-binding cassette, subfamily B, member 11 (bile salt export pump)	603201	ABCB11	8647	ENSG00000073734,ENST00000650372;;;ENST00000650372		Cholestasis, benign recurrent intrahepatic, 2	605479	Autosomal recessive	3	Abcb11
2q31.1	2:168915390-169031324	ABCB11, BSEP, SPGP, PFIC2, BRIC2	ATP-binding cassette, subfamily B, member 11 (bile salt export pump)	603201	ABCB11	8647	ENSG00000073734,ENST00000650372;;;ENST00000650372		Cholestasis, progressive familial intrahepatic 2	601847	Autosomal recessive	3	Abcb11
2q31.2	2:178525989-178807423	TTN, CMD1G, TMD, LGMDR10, MPRM, HMERF, CMYP5	Titin	188840	TTN	7273	ENSG00000155657,ENST00000589042;;;ENST00000589042		Cardiomyopathy, dilated, 1G	604145	Autosomal dominant	3	Ttn
2q31.2	2:178525989-178807423	TTN, CMD1G, TMD, LGMDR10, MPRM, HMERF, CMYP5	Titin	188840	TTN	7273	ENSG00000155657,ENST00000589042;;;ENST00000589042		Cardiomyopathy, familial hypertrophic, 9	613765	Autosomal dominant	3	Ttn
2q31.2	2:178525989-178807423	TTN, CMD1G, TMD, LGMDR10, MPRM, HMERF, CMYP5	Titin	188840	TTN	7273	ENSG00000155657,ENST00000589042;;;ENST00000589042		Congenital myopathy 5 with cardiomyopathy	611705	Autosomal recessive	3	Ttn
2q31.2	2:178525989-178807423	TTN, CMD1G, TMD, LGMDR10, MPRM, HMERF, CMYP5	Titin	188840	TTN	7273	ENSG00000155657,ENST00000589042;;;ENST00000589042		Muscular dystrophy, limb-girdle, autosomal recessive 10	608807	Autosomal recessive	3	Ttn
2q31.2	2:178525989-178807423	TTN, CMD1G, TMD, LGMDR10, MPRM, HMERF, CMYP5	Titin	188840	TTN	7273	ENSG00000155657,ENST00000589042;;;ENST00000589042		Myopathy, myofibrillar, 9, with early respiratory failure	603689	Autosomal dominant	3	Ttn
2q31.2	2:178525989-178807423	TTN, CMD1G, TMD, LGMDR10, MPRM, HMERF, CMYP5	Titin	188840	TTN	7273	ENSG00000155657,ENST00000589042;;;ENST00000589042		Tibial muscular dystrophy, tardive	600334	Autosomal dominant	3	Ttn
2q33.1-q33.2	2:202376327-202567749	BMPR2, PPH1, POVD1	Bone morphogenetic receptor, type II	600799	BMPR2	659	ENSG00000204217,ENST00000374580;;;ENST00000374580		Pulmonary hypertension, familial primary, 1, with or without HHT	178600	Autosomal dominant	3	Bmpr2
2q33.1-q33.2	2:202376327-202567749	BMPR2, PPH1, POVD1	Bone morphogenetic receptor, type II	600799	BMPR2	659	ENSG00000204217,ENST00000374580;;;ENST00000374580		Pulmonary hypertension, primary, fenfluramine or dexfenfluramine-associated	178600	Autosomal dominant	3	Bmpr2
2q33.1-q33.2	2:202376327-202567749	BMPR2, PPH1, POVD1	Bone morphogenetic receptor, type II	600799	BMPR2	659	ENSG00000204217,ENST00000374580;;;ENST00000374580		Pulmonary venoocclusive disease 1	265450	Autosomal dominant	3	Bmpr2
2q35-q36	2:214500001-230100000	PSHK2	Pseudohyperkalemia, familial, 2, due to red cell leak	609153				max lod at D2S1338	Pseudohyperkalemia, familial, 2, due to red cell leak	609153	Autosomal dominant	2	
2q35	2:219209772-219218958	ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2	ATP-binding cassette, subfamily B, member 6	605452	ABCB6	10058	ENSG00000115657,ENST00000265316;;;ENST00000265316		Dyschromatosis universalis hereditaria 3	615402	Autosomal dominant	3	Abcb6
2q35	2:219209772-219218958	ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2	ATP-binding cassette, subfamily B, member 6	605452	ABCB6	10058	ENSG00000115657,ENST00000265316;;;ENST00000265316		Microphthalmia, isolated, with coloboma 7	614497	Autosomal dominant	3	Abcb6
2q35	2:219209772-219218958	ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2	ATP-binding cassette, subfamily B, member 6	605452	ABCB6	10058	ENSG00000115657,ENST00000265316;;;ENST00000265316		Pseudohyperkalemia, familial, 2, due to red cell leak	609153	Autosomal dominant	3	Abcb6
2q35	2:219209772-219218958	ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2	ATP-binding cassette, subfamily B, member 6	605452	ABCB6	10058	ENSG00000115657,ENST00000265316;;;ENST00000265316		[Blood group, Langereis system]	111600		3	Abcb6
2q36.3	2:226967360-227164488	COL4A4, ATS2, BFH1	Collagen IV, alpha-4 polypeptide	120131	COL4A4	1286	ENSG00000081052,ENST00000396625;;;ENST00000396625	head-to-head with COL4A4 in same YAC	Alport syndrome 2, autosomal recessive	203780	Autosomal recessive	3	Col4a4
2q36.3	2:226967360-227164488	COL4A4, ATS2, BFH1	Collagen IV, alpha-4 polypeptide	120131	COL4A4	1286	ENSG00000081052,ENST00000396625;;;ENST00000396625	head-to-head with COL4A4 in same YAC	Hematuria, familial benign, 1	141200	Autosomal dominant	3	Col4a4
2q36.3	2:227164624-227314792	COL4A3, ATS2, ATS3, BFH2	Collagen IV, alpha-3 polypeptide (Goodpasture antigen)	120070	COL4A3	1285	ENSG00000169031,ENST00000396578;;;ENST00000396578	noncollagenous domain = Goodpasture antigen	Alport syndrome 2, autosomal recessive	203780	Autosomal recessive	3	Col4a3
2q36.3	2:227164624-227314792	COL4A3, ATS2, ATS3, BFH2	Collagen IV, alpha-3 polypeptide (Goodpasture antigen)	120070	COL4A3	1285	ENSG00000169031,ENST00000396578;;;ENST00000396578	noncollagenous domain = Goodpasture antigen	Alport syndrome 3, autosomal dominant	104200	Autosomal dominant	3	Col4a3
2q36.3	2:227164624-227314792	COL4A3, ATS2, ATS3, BFH2	Collagen IV, alpha-3 polypeptide (Goodpasture antigen)	120070	COL4A3	1285	ENSG00000169031,ENST00000396578;;;ENST00000396578	noncollagenous domain = Goodpasture antigen	Hematuria, benign familial, 2	620320		3	Col4a3
2q37.1	2:233760270-233773300	UGT1A1, UGT1, GNT1, BILIQTL1	UDP glycosyltransferase 1 family, polypeptide A1	191740	UGT1A1	54658	ENSG00000241635,ENST00000305208;;;ENST00000305208		Crigler-Najjar syndrome, type I	218800	Autosomal recessive	3	Ugt1a1
2q37.1	2:233760270-233773300	UGT1A1, UGT1, GNT1, BILIQTL1	UDP glycosyltransferase 1 family, polypeptide A1	191740	UGT1A1	54658	ENSG00000241635,ENST00000305208;;;ENST00000305208		Crigler-Najjar syndrome, type II	606785	Autosomal recessive	3	Ugt1a1
2q37.1	2:233760270-233773300	UGT1A1, UGT1, GNT1, BILIQTL1	UDP glycosyltransferase 1 family, polypeptide A1	191740	UGT1A1	54658	ENSG00000241635,ENST00000305208;;;ENST00000305208		Hyperbilirubinemia, familial transient neonatal	237900	Autosomal dominant; Autosomal recessive	3	Ugt1a1
2q37.1	2:233760270-233773300	UGT1A1, UGT1, GNT1, BILIQTL1	UDP glycosyltransferase 1 family, polypeptide A1	191740	UGT1A1	54658	ENSG00000241635,ENST00000305208;;;ENST00000305208		[Bilirubin, serum level of, QTL1]	601816		3	Ugt1a1
2q37.1	2:233760270-233773300	UGT1A1, UGT1, GNT1, BILIQTL1	UDP glycosyltransferase 1 family, polypeptide A1	191740	UGT1A1	54658	ENSG00000241635,ENST00000305208;;;ENST00000305208		[Gilbert syndrome]	143500	Autosomal recessive	3	Ugt1a1
2q37.3	2:238244044-238300065	PER2, FASPS1, KIAA0347	Period circadian regulator 2	603426	PER2	8864	ENSG00000132326,ENST00000254657;;;ENST00000254657	mutation identified in 1 FASPS1 family	?Advanced sleep phase syndrome, familial, 1	604348	Autosomal dominant	3	Per2
3p25.3	3:8733802-8746758	CAV3, LQT9, MPDT, RMD2	Caveolin-3	601253	CAV3	859	ENSG00000182533,ENST00000343849;;;ENST00000343849	within 7-10kb of OXTR	Cardiomyopathy, familial hypertrophic	192600	Autosomal dominant; Digenic dominant	3	Cav3
3p25.3	3:8733802-8746758	CAV3, LQT9, MPDT, RMD2	Caveolin-3	601253	CAV3	859	ENSG00000182533,ENST00000343849;;;ENST00000343849	within 7-10kb of OXTR	Creatine phosphokinase, elevated serum	123320	Autosomal dominant	3	Cav3
3p25.3	3:8733802-8746758	CAV3, LQT9, MPDT, RMD2	Caveolin-3	601253	CAV3	859	ENSG00000182533,ENST00000343849;;;ENST00000343849	within 7-10kb of OXTR	Long QT syndrome 9	611818	Autosomal dominant	3	Cav3
3p25.3	3:8733802-8746758	CAV3, LQT9, MPDT, RMD2	Caveolin-3	601253	CAV3	859	ENSG00000182533,ENST00000343849;;;ENST00000343849	within 7-10kb of OXTR	Myopathy, distal, Tateyama type	614321	Autosomal dominant	3	Cav3
3p25.3	3:8733802-8746758	CAV3, LQT9, MPDT, RMD2	Caveolin-3	601253	CAV3	859	ENSG00000182533,ENST00000343849;;;ENST00000343849	within 7-10kb of OXTR	Rippling muscle disease 2	606072	Autosomal dominant	3	Cav3
3p25.3	3:9866710-9880253	CIDEC, FSP27, CIDE3, FPLD5	Cell death-inducing DFFA-like effector C	612120	CIDEC	63924	ENSG00000187288,ENST00000336832;;;ENST00000336832	1 patient identified with mutation	?Lipodystrophy, familial partial, type 5	615238	Autosomal recessive	3	Cidec
3p25.3	3:9917098-9933621	IL17RC, IL17RL, CANDF9	Interleukin 17 receptor C	610925	IL17RC	84818	ENSG00000163702,ENST00000403601;;;ENST00000403601		Candidiasis, familial, 9	616445	Autosomal recessive	3	Il17rc
3p25.3	3:10141778-10153667	VHL	von Hippel-Lindau tumor suppressor	608537	VHL	7428	ENSG00000134086,ENST00000256474;;;ENST00000256474		Erythrocytosis, familial, 2	263400	Autosomal recessive	3	Vhl
3p25.3	3:10141778-10153667	VHL	von Hippel-Lindau tumor suppressor	608537	VHL	7428	ENSG00000134086,ENST00000256474;;;ENST00000256474		Hemangioblastoma, cerebellar, somatic			3	Vhl
3p25.3	3:10141778-10153667	VHL	von Hippel-Lindau tumor suppressor	608537	VHL	7428	ENSG00000134086,ENST00000256474;;;ENST00000256474		Pheochromocytoma	171300	Autosomal dominant	3	Vhl
3p25.3	3:10141778-10153667	VHL	von Hippel-Lindau tumor suppressor	608537	VHL	7428	ENSG00000134086,ENST00000256474;;;ENST00000256474		Renal cell carcinoma, somatic	144700		3	Vhl
3p25.3	3:10141778-10153667	VHL	von Hippel-Lindau tumor suppressor	608537	VHL	7428	ENSG00000134086,ENST00000256474;;;ENST00000256474		von Hippel-Lindau syndrome	193300	Autosomal dominant	3	Vhl
3p25.2	3:12287368-12434344	PPARG, PPARG1, PPARG2, CIMT1, GLM1	Peroxisome proliferator activated receptor, gamma	601487	PPARG	5468	ENSG00000132170,ENST00000651735;;;ENST00000651735	PPARG1, PPARG2 from same gene	Carotid intimal medial thickness 1	609338		3	Pparg
3p25.2	3:12287368-12434344	PPARG, PPARG1, PPARG2, CIMT1, GLM1	Peroxisome proliferator activated receptor, gamma	601487	PPARG	5468	ENSG00000132170,ENST00000651735;;;ENST00000651735	PPARG1, PPARG2 from same gene	Insulin resistance, severe, digenic	604367	Autosomal dominant	3	Pparg
3p25.2	3:12287368-12434344	PPARG, PPARG1, PPARG2, CIMT1, GLM1	Peroxisome proliferator activated receptor, gamma	601487	PPARG	5468	ENSG00000132170,ENST00000651735;;;ENST00000651735	PPARG1, PPARG2 from same gene	Lipodystrophy, familial partial, type 3	604367	Autosomal dominant	3	Pparg
3p25.2	3:12287368-12434344	PPARG, PPARG1, PPARG2, CIMT1, GLM1	Peroxisome proliferator activated receptor, gamma	601487	PPARG	5468	ENSG00000132170,ENST00000651735;;;ENST00000651735	PPARG1, PPARG2 from same gene	Obesity, severe	601665	Autosomal dominant; Autosomal recessive; Multifactorial	3	Pparg
3p25.2	3:12287368-12434344	PPARG, PPARG1, PPARG2, CIMT1, GLM1	Peroxisome proliferator activated receptor, gamma	601487	PPARG	5468	ENSG00000132170,ENST00000651735;;;ENST00000651735	PPARG1, PPARG2 from same gene	[Obesity, resistance to]			3	Pparg
3p25.2	3:12287368-12434344	PPARG, PPARG1, PPARG2, CIMT1, GLM1	Peroxisome proliferator activated receptor, gamma	601487	PPARG	5468	ENSG00000132170,ENST00000651735;;;ENST00000651735	PPARG1, PPARG2 from same gene	{Diabetes, type 2}	125853	Autosomal dominant	3	Pparg
3p24.2-p23	3:23800001-32000000	FEB9	Febrile seizures, familial, 9	611634		100188849		between D3S3727 and D3S3567	Febrile seizures, familial, 9	611634	Autosomal dominant	2	
3p22.2	3:38548062-38649687	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	Sodium channel, voltage-gated, type V, alpha polypeptide	600163	SCN5A	6331	ENSG00000183873,ENST00000423572;;;ENST00000423572		Atrial fibrillation, familial, 10	614022	Autosomal dominant	3	Scn5a
3p22.2	3:38548062-38649687	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	Sodium channel, voltage-gated, type V, alpha polypeptide	600163	SCN5A	6331	ENSG00000183873,ENST00000423572;;;ENST00000423572		Brugada syndrome 1	601144	Autosomal dominant	3	Scn5a
3p22.2	3:38548062-38649687	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	Sodium channel, voltage-gated, type V, alpha polypeptide	600163	SCN5A	6331	ENSG00000183873,ENST00000423572;;;ENST00000423572		Cardiomyopathy, dilated, 1E	601154	Autosomal dominant	3	Scn5a
3p22.2	3:38548062-38649687	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	Sodium channel, voltage-gated, type V, alpha polypeptide	600163	SCN5A	6331	ENSG00000183873,ENST00000423572;;;ENST00000423572		Heart block, nonprogressive	113900	Autosomal dominant	3	Scn5a
3p22.2	3:38548062-38649687	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	Sodium channel, voltage-gated, type V, alpha polypeptide	600163	SCN5A	6331	ENSG00000183873,ENST00000423572;;;ENST00000423572		Heart block, progressive, type IA	113900	Autosomal dominant	3	Scn5a
3p22.2	3:38548062-38649687	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	Sodium channel, voltage-gated, type V, alpha polypeptide	600163	SCN5A	6331	ENSG00000183873,ENST00000423572;;;ENST00000423572		Long QT syndrome 3	603830	Autosomal dominant	3	Scn5a
3p22.2	3:38548062-38649687	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	Sodium channel, voltage-gated, type V, alpha polypeptide	600163	SCN5A	6331	ENSG00000183873,ENST00000423572;;;ENST00000423572		Sick sinus syndrome 1	608567	Autosomal recessive	3	Scn5a
3p22.2	3:38548062-38649687	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	Sodium channel, voltage-gated, type V, alpha polypeptide	600163	SCN5A	6331	ENSG00000183873,ENST00000423572;;;ENST00000423572		Ventricular fibrillation, familial, 1	603829		3	Scn5a
3p22.2	3:38548062-38649687	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	Sodium channel, voltage-gated, type V, alpha polypeptide	600163	SCN5A	6331	ENSG00000183873,ENST00000423572;;;ENST00000423572		{Sudden infant death syndrome, susceptibility to}	272120	Autosomal recessive	3	Scn5a
3p22.2	3:38696807-38816217	SCN10A, FEPS2	Sodium voltage-gated channel, alpha subunit 10	604427	SCN10A	6336	ENSG00000185313,ENST00000449082;;;ENST00000449082		Episodic pain syndrome, familial, 2	615551	Autosomal dominant	3	Scn10a
3p22.2	3:38845764-39051944	SCN11A, HSAN7, FEPS3	Sodium voltage-gated channel, alpha subunit 11	604385	SCN11A	11280	ENSG00000168356,ENST00000302328;;;ENST00000302328		Episodic pain syndrome, familial, 3	615552	Autosomal dominant	3	Scn11a
3p22.2	3:38845764-39051944	SCN11A, HSAN7, FEPS3	Sodium voltage-gated channel, alpha subunit 11	604385	SCN11A	11280	ENSG00000168356,ENST00000302328;;;ENST00000302328		Neuropathy, hereditary sensory and autonomic, type VII	615548	Autosomal dominant	3	Scn11a
3p21.31	3:50347330-50350775	NPRL2, FFEVF2	NPR2-like protein, GATOR1 complex subunit	607072	NPRL2	10641	ENSG00000114388,ENST00000232501;;;ENST00000232501		Epilepsy, familial focal, with variable foci 2	617116	Autosomal dominant	3	Nprl2
3q13.2-q13.33	3:111600001-122200000	STUT3	Stuttering, familial persistent, 3	614655		100909386		max lod at D3S1310	Stuttering, familial persistent, 3	614655		2	
3q21.1	3:123610049-123884332	MYLK, MLCK, AAT7, MMIHS1	Myosin-light-polypeptide kinase	600922	MYLK	4638	ENSG00000065534,ENST00000360304;;;ENST00000360304	pseudogene on 3p13	Aortic aneurysm, familial thoracic 7	613780	Autosomal dominant	3	Mylk
3q21.1	3:123610049-123884332	MYLK, MLCK, AAT7, MMIHS1	Myosin-light-polypeptide kinase	600922	MYLK	4638	ENSG00000065534,ENST00000360304;;;ENST00000360304	pseudogene on 3p13	Megacystis-microcolon-intestinal hypoperistalsis syndrome 1	249210	Autosomal recessive	3	Mylk
3q23	3:140941836-140980995	SLC25A36, PNC2, HHF8	Solute carrier family 25 (mitochondrial carrier, pyrimidine nucleotide transporter), member 36	616149	SLC25A36	55186	ENSG00000114120,ENST00000324194;;;ENST00000324194		Hyperinsulinemic hypoglycemia, familial, 8	620211	Autosomal recessive	3	Slc25a36
3q23	3:142449235-142578733	ATR, FRP1, SCKL1, FCTCS	ATR serine/threonine kinase	601215	ATR	545	ENSG00000175054,ENST00000350721;;;ENST00000350721	mutation identified in 1 FCTCS family	?Cutaneous telangiectasia and cancer syndrome, familial	614564	Autosomal dominant	3	Atr
3q23	3:142449235-142578733	ATR, FRP1, SCKL1, FCTCS	ATR serine/threonine kinase	601215	ATR	545	ENSG00000175054,ENST00000350721;;;ENST00000350721	mutation identified in 1 FCTCS family	Seckel syndrome 1	210600	Autosomal recessive	3	Atr
3q25-q26	3:149200001-183000000	ETL6	Epilepsy, familial temporal lobe, 6	615697		103106902		between D3S1584 and D3S3520	Epilepsy, familial temporal lobe, 6	615697	Autosomal dominant	2	
3q26.1	3:167735721-167825569	SERPINI1, PI12	Protease inhibitor 12	602445	SERPINI1	5274	ENSG00000163536,ENST00000446050;;;ENST00000446050		Encephalopathy, familial, with neuroserpin inclusion bodies	604218	Autosomal dominant	3	Serpini1
3q26.2-q26.33	3:167900001-183000000	FEB10	Febrile seizures, familial, 10	612637		100271923		between D3S3656 and D3S1232	Febrile seizures, familial, 10	612637		2	
3q27.1	3:183635623-183684519	KLHL24, KRIP6, EBS6, CMH29	Kelch-like 24	611295	KLHL24	54800	ENSG00000114796,ENST00000242810;;;ENST00000242810		Cardiomyopathy, familial hypertrophic, 29, with polyglucosan bodies	620236	Autosomal recessive	3	Klhl24
3q27.1	3:183635623-183684519	KLHL24, KRIP6, EBS6, CMH29	Kelch-like 24	611295	KLHL24	54800	ENSG00000114796,ENST00000242810;;;ENST00000242810		Epidermolysis bullosa simplex 6, generalized intermediate, with or without cardiomyopathy	617294	Autosomal dominant	3	Klhl24
3q27.1	3:183697797-183812624	YEATS2, KIAA1197, FAME4	YEATS domain-containing protein 2	613373	YEATS2	55689	ENSG00000163872,ENST00000305135;;;ENST00000305135	mutation identifed in 1 FAME4 family	?Epilepsy, myoclonic, familial adult, 4	615127	Autosomal dominant	3	Yeats2
3q27.1	3:184346185-184361605	CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT, HALD2	Chloride channel-2	600570	CLCN2	1181	ENSG00000114859,ENST00000265593;;;ENST00000265593		Hyperaldosteronism, familial, type II	605635	Autosomal dominant	3	Clcn2
3q27.1	3:184346185-184361605	CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT, HALD2	Chloride channel-2	600570	CLCN2	1181	ENSG00000114859,ENST00000265593;;;ENST00000265593		Leukoencephalopathy with ataxia	615651	Autosomal recessive	3	Clcn2
3q27.1	3:184346185-184361605	CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT, HALD2	Chloride channel-2	600570	CLCN2	1181	ENSG00000114859,ENST00000265593;;;ENST00000265593		{Epilepsy, idiopathic generalized, susceptibility to, 11}	607628	Autosomal dominant	3	Clcn2
3q27.1	3:184346185-184361605	CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT, HALD2	Chloride channel-2	600570	CLCN2	1181	ENSG00000114859,ENST00000265593;;;ENST00000265593		{Epilepsy, juvenile absence, susceptibility to, 2}	607628	Autosomal dominant	3	Clcn2
3q27.1	3:184346185-184361605	CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT, HALD2	Chloride channel-2	600570	CLCN2	1181	ENSG00000114859,ENST00000265593;;;ENST00000265593		{Epilepsy, juvenile myoclonic, susceptibility to, 8}	607628	Autosomal dominant	3	Clcn2
3q29	3:196216534-196233427	SLC51A, OSTA, PFIC6	Solute carrier family 51, alpha subunit (organic solute transporter, alpha)	612084	SLC51A	200931	ENSG00000163959,ENST00000296327;;;ENST00000296327	mutation identified in 1 PFIC6 patient	?Cholestasis, progressive familial intrahepatic, 6	619484	Autosomal recessive	3	Slc51a
4q12	4:54229293-54298245	PDGFRA	Platelet-derived growth factor receptor, alpha polypeptide	173490	PDGFRA	5156	ENSG00000134853,ENST00000257290;;;ENST00000257290	same 700bp segment as KIT; fused to BCR or FIP1L1	Gastrointestinal stromal tumor/GIST-plus syndrome, somatic or familial	175510		3	Pdgfra
4q12	4:54229293-54298245	PDGFRA	Platelet-derived growth factor receptor, alpha polypeptide	173490	PDGFRA	5156	ENSG00000134853,ENST00000257290;;;ENST00000257290	same 700bp segment as KIT; fused to BCR or FIP1L1	Hypereosinophilic syndrome, idiopathic, resistant to imatinib	607685	Isolated cases; Somatic mutation	3	Pdgfra
4q12	4:54657957-54740715	KIT, PBT, MASTC	Hardy-Zuckerman 4 feline sarcoma (v-kit) oncogene	164920	KIT	3815	ENSG00000157404,ENST00000288135;;;ENST00000288135	same 700bp segment as PDGFRA	Gastrointestinal stromal tumor, familial	606764	Autosomal dominant; Isolated cases	3	Kit
4q12	4:54657957-54740715	KIT, PBT, MASTC	Hardy-Zuckerman 4 feline sarcoma (v-kit) oncogene	164920	KIT	3815	ENSG00000157404,ENST00000288135;;;ENST00000288135	same 700bp segment as PDGFRA	Germ cell tumors, somatic	273300		3	Kit
4q12	4:54657957-54740715	KIT, PBT, MASTC	Hardy-Zuckerman 4 feline sarcoma (v-kit) oncogene	164920	KIT	3815	ENSG00000157404,ENST00000288135;;;ENST00000288135	same 700bp segment as PDGFRA	Leukemia, acute myeloid, somatic	601626		3	Kit
4q12	4:54657957-54740715	KIT, PBT, MASTC	Hardy-Zuckerman 4 feline sarcoma (v-kit) oncogene	164920	KIT	3815	ENSG00000157404,ENST00000288135;;;ENST00000288135	same 700bp segment as PDGFRA	Mastocytosis, cutaneous	154800	Autosomal dominant	3	Kit
4q12	4:54657957-54740715	KIT, PBT, MASTC	Hardy-Zuckerman 4 feline sarcoma (v-kit) oncogene	164920	KIT	3815	ENSG00000157404,ENST00000288135;;;ENST00000288135	same 700bp segment as PDGFRA	Mastocytosis, systemic, somatic	154800		3	Kit
4q12	4:54657957-54740715	KIT, PBT, MASTC	Hardy-Zuckerman 4 feline sarcoma (v-kit) oncogene	164920	KIT	3815	ENSG00000157404,ENST00000288135;;;ENST00000288135	same 700bp segment as PDGFRA	Piebaldism	172800	Autosomal dominant	3	Kit
4q13.2-q21.3	4:65500001-87100000	ETL3, FMTLE	Epilepsy, familial temporal lobe, 3	611630		100188848		max lod at D4S1517	Epilepsy, familial temporal lobe, 3	611630	Autosomal dominant	2	
4q25	4:106700001-113200000	ATFB5	Atrial fibrillation, familial, 5	611494		100188842		association with rs2200733 and rs10033464	{Atrial fibrillation, familial, 5}	611494		2	
4q25	4:107989889-108035171	HADHSC, SCHAD, HHF4	L-3-hydroxyacyl-CoA dehydrogenase, short chain	601609	HADH	3033	ENSG00000138796,ENST00000309522;;;ENST00000309522		3-hydroxyacyl-CoA dehydrogenase deficiency	231530	Autosomal recessive	3	Hadh
4q25	4:107989889-108035171	HADHSC, SCHAD, HHF4	L-3-hydroxyacyl-CoA dehydrogenase, short chain	601609	HADH	3033	ENSG00000138796,ENST00000309522;;;ENST00000309522		Hyperinsulinemic hypoglycemia, familial, 4	609975	Autosomal recessive	3	Hadh
4q26	4:119212601-119295518	USP53, KIAA1350, PFIC7	Ubiquitin-specific peptidase 53	617431	USP53	54532	ENSG00000145390,ENST00000692078;;;ENST00000692078		Cholestasis, progressive familial intrahepatic, 7, with or without hearing loss	619658	Autosomal recessive	3	Usp53
4q31	4:138500001-154600000	AAA2	Aortic aneurysm, familial abdominal 2	609782		100505390		max lod at D4S1644	Aortic aneurysm, familial abdominal 2	609782		2	
4q31.3	4:154583126-154590742	FGA	Fibrinogen, alpha polypeptide	134820	FGA	2243	ENSG00000171560,ENST00000403106;;;ENST00000403106		Afibrinogenemia, congenital	202400	Autosomal recessive	3	Fga
4q31.3	4:154583126-154590742	FGA	Fibrinogen, alpha polypeptide	134820	FGA	2243	ENSG00000171560,ENST00000403106;;;ENST00000403106		Amyloidosis, familial visceral	105200	Autosomal dominant	3	Fga
4q31.3	4:154583126-154590742	FGA	Fibrinogen, alpha polypeptide	134820	FGA	2243	ENSG00000171560,ENST00000403106;;;ENST00000403106		Dysfibrinogenemia, congenital	616004		3	Fga
4q31.3	4:154583126-154590742	FGA	Fibrinogen, alpha polypeptide	134820	FGA	2243	ENSG00000171560,ENST00000403106;;;ENST00000403106		Hypodysfibrinogenemia, congenital	616004		3	Fga
4q32.1	4:159103079-159360173	RAPGEF2, NRAPGEP, RAGEF, KIAA0313	Rap guanine nucleotide exchange factor 2	609530	RAPGEF2	9693	ENSG00000109756,ENST00000691494;;;ENST00000691494	mutation identified in 1 FAME7 patient	?Epilepsy, familial adult myoclonic, 7	618075	Autosomal dominant	3	Rapgef2
5p15.2	5:10353695-10440388	MARCH6, TEB4, DOA10, KIAA0597, FAME3	Membrane-associated RING-CH finger protein 6	613297	MARCHF6	10299	ENSG00000145495,ENST00000274140;;;ENST00000274140		Epilepsy, familial adult myoclonic, 3	613608	Autosomal dominant	3	Marchf6
5p13.1-p12	5:42423439-42721878	GHR, GHIP	Growth hormone receptor	600946	GHR	2690	ENSG00000112964,ENST00000230882;;;ENST00000230882		Growth hormone insensitivity, partial	604271	Autosomal dominant	3	Ghr
5p13.1-p12	5:42423439-42721878	GHR, GHIP	Growth hormone receptor	600946	GHR	2690	ENSG00000112964,ENST00000230882;;;ENST00000230882		Increased responsiveness to growth hormone	604271	Autosomal dominant	3	Ghr
5p13.1-p12	5:42423439-42721878	GHR, GHIP	Growth hormone receptor	600946	GHR	2690	ENSG00000112964,ENST00000230882;;;ENST00000230882		Laron dwarfism	262500	Autosomal recessive	3	Ghr
5p13.1-p12	5:42423439-42721878	GHR, GHIP	Growth hormone receptor	600946	GHR	2690	ENSG00000112964,ENST00000230882;;;ENST00000230882		{Hypercholesterolemia, familial, modifier of}	143890	Autosomal dominant; Autosomal recessive	3	Ghr
5q13-q14	5:67400001-93000000	AAT2, FAA2	Aortic aneurysm, familial thoracic 2	607087		252843			Aortic aneurysm, familial thoracic 2	607087		2	
5q14.1	5:80654652-80876815	MSH3, FAP4	mutS homolog 3	600887	MSH3	4437	ENSG00000113318,ENST00000265081;;;ENST00000265081	5' to DHFR	Endometrial carcinoma, somatic	608089		3	Msh3
5q14.1	5:80654652-80876815	MSH3, FAP4	mutS homolog 3	600887	MSH3	4437	ENSG00000113318,ENST00000265081;;;ENST00000265081	5' to DHFR	Familial adenomatous polyposis 4	617100	Autosomal recessive	3	Msh3
5q14.3	5:90558797-91164437	ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C	Adhesion G protein-coupled receptor V1	602851	ADGRV1	84059	ENSG00000164199,ENST00000405460;;;ENST00000405460	mutation identified in 1 FEB4 family	?Febrile seizures, familial, 4	604352	Autosomal dominant	3	Adgrv1
5q14.3	5:90558797-91164437	ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C	Adhesion G protein-coupled receptor V1	602851	ADGRV1	84059	ENSG00000164199,ENST00000405460;;;ENST00000405460	mutation identified in 1 FEB4 family	Usher syndrome, type 2C	605472	Autosomal recessive; Digenic dominant	3	Adgrv1
5q14.3	5:90558797-91164437	ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C	Adhesion G protein-coupled receptor V1	602851	ADGRV1	84059	ENSG00000164199,ENST00000405460;;;ENST00000405460	mutation identified in 1 FEB4 family	Usher syndrome, type 2C, GPR98/PDZD7 digenic	605472	Autosomal recessive; Digenic dominant	3	Adgrv1
5q23.1	5:122063195-122078259	LOX, AAT10	Lysyl oxidase	153455	LOX	4015	ENSG00000113083,ENST00000231004;;;ENST00000231004		Aortic aneurysm, familial thoracic 10	617168	Autosomal dominant	3	Lox
5q31-q33	5:131200001-160500000	EOS	Eosinophilia, familial	131400		7908			Eosinophilia, familial	131400	Autosomal dominant	2	
5q31.2	5:138179112-138187723	KIF20A, RAB6KIFL, RCM6	Kinesin family member 20A	605664	KIF20A	10112	ENSG00000112984,ENST00000394894;;;ENST00000394894	mutation identified in 1 RCM6 family	?Cardiomyopathy, familial restrictive, 6	619433	Autosomal recessive	3	Kif20a
5q34	5:162067465-162155539	GABRG2, DEE74, FEB8, ECA2, GEFSP3	Gamma-aminobutyric acid (GABA) A receptor, gamma-2	137164	GABRG2	2566	ENSG00000113327,ENST00000639213;;;ENST00000639213	in alpha/beta/gamma cluster	Developmental and epileptic encephalopathy 74	618396	Autosomal dominant	3	Gabrg2
5q34	5:162067465-162155539	GABRG2, DEE74, FEB8, ECA2, GEFSP3	Gamma-aminobutyric acid (GABA) A receptor, gamma-2	137164	GABRG2	2566	ENSG00000113327,ENST00000639213;;;ENST00000639213	in alpha/beta/gamma cluster	Febrile seizures, familial, 8	607681	Autosomal dominant	3	Gabrg2
5q34	5:162067465-162155539	GABRG2, DEE74, FEB8, ECA2, GEFSP3	Gamma-aminobutyric acid (GABA) A receptor, gamma-2	137164	GABRG2	2566	ENSG00000113327,ENST00000639213;;;ENST00000639213	in alpha/beta/gamma cluster	Generalized epilepsy with febrile seizures plus, type 3	607681	Autosomal dominant	3	Gabrg2
5q35.3	5:177511577-177516961	DDX41, ABS, MPLPF	DEAD-box helicase 41	608170	DDX41	51428	ENSG00000183258,ENST00000330503;;;ENST00000330503		{Myeloproliferative/lymphoproliferative neoplasms, familial (multiple types), susceptibility to}	616871	Autosomal dominant	3	Ddx41
6p24.2	6:10873223-10882041	GCM2, GCMB, HRPT4, FIH2	Glial cells missing transcription factor 2	603716	GCM2	9247	ENSG00000124827,ENST00000379491;;;ENST00000379491		Hyperparathyroidism 4	617343	Autosomal dominant	3	Gcm2
6p24.2	6:10873223-10882041	GCM2, GCMB, HRPT4, FIH2	Glial cells missing transcription factor 2	603716	GCM2	9247	ENSG00000124827,ENST00000379491;;;ENST00000379491		Hypoparathyroidism, familial isolated 2	618883	Autosomal dominant; Autosomal recessive	3	Gcm2
6p21.3	6:30500001-36600000	ATPLS	Antiphospholipid syndrome, familial	107320		100499532		possible linkage with HLA-DRB1*14	?Antiphospholipid syndrome, familial	107320	Autosomal dominant	2	
6p12.2	6:52236681-52245689	IL17F, ML1, CANDF6	Interleukin 17F	606496	IL17F	112744	ENSG00000112116,ENST00000336123;;;ENST00000336123	mutation identified in 1 CANDF6 family	?Candidiasis, familial, 6, autosomal dominant	613956		3	Il17f
6q	6:59800001-170805979	BPPV	Vertigo, benign paroxysmal positional	193007		619536		max lod at D6S1556	Vestibulopathy, familial	193007	Autosomal dominant	2	
6q14-q16	6:75200001-105000000	ATFB2	Atrial fibrillation, familial, 2	608988		619478		max lod between  D6S286 and D6S1021	Atrial fibrillation, familial, 2	608988		2	
6q21	6:111555381-111605878	TRAF3IP2, C6orf5, ACT1, CIKS, C6orf4, C6orf6, PSORS13, CANDF8	TRAF3-interacting protein 2	607043	TRAF3IP2	10758	ENSG00000056972,ENST00000368761;;;ENST00000368761	mutation identified in 1 family with CANDF8	?Candidiasis, familial, 8	615527	Autosomal recessive	3	Traf3ip2
6q21	6:111555381-111605878	TRAF3IP2, C6orf5, ACT1, CIKS, C6orf4, C6orf6, PSORS13, CANDF8	TRAF3-interacting protein 2	607043	TRAF3IP2	10758	ENSG00000056972,ENST00000368761;;;ENST00000368761	mutation identified in 1 family with CANDF8	{Psoriasis susceptibility 13}	614070		3	Traf3ip2
6q22-q24	6:114200001-148500000	FEB5	Febrile seizures, familial, 5	609255		619398		between D6S1572 and D6S472	Febrile seizures, familial, 5	609255	Autosomal dominant	2	
6q23.3	6:137866349-137883312	TNFAIP3, A20, OTUD7C, AIFBL1	Tumor necrosis factor-alpha-induced protein 3	191163	TNFAIP3	7128	ENSG00000118503,ENST00000612899;;;ENST00000612899		Autoinflammatory syndrome, familial, Behcet-like 1	616744	Autosomal dominant	3	Tnfaip3
6q24.2	6:144139963-144191939	STX11, FHL4, HPLH4, HLH4	Syntaxin-11	605014	STX11	8676	ENSG00000135604,ENST00000367568;;;ENST00000367568		Hemophagocytic lymphohistiocytosis, familial, 4	603552	Autosomal recessive	3	Stx11
7p14.3	7:31687215-31708455	GSBS	G-substrate	604088	PPP1R17	10842	ENSG00000106341,ENST00000342032;;;ENST00000342032		{Hypercholesterolemia, susceptibility to}	143890	Autosomal dominant; Autosomal recessive	3	Ppp1r17
7p13	7:44143213-44189439	GCK, HHF3, PNDM1	Glucokinase (hexokinase-4)	138079	GCK	2645	ENSG00000106633,ENST00000403799;;;ENST00000403799	proximal to TCRB	Diabetes mellitus, noninsulin-dependent, late onset	125853	Autosomal dominant	3	Gck
7p13	7:44143213-44189439	GCK, HHF3, PNDM1	Glucokinase (hexokinase-4)	138079	GCK	2645	ENSG00000106633,ENST00000403799;;;ENST00000403799	proximal to TCRB	Diabetes mellitus, permanent neonatal 1	606176	Autosomal recessive	3	Gck
7p13	7:44143213-44189439	GCK, HHF3, PNDM1	Glucokinase (hexokinase-4)	138079	GCK	2645	ENSG00000106633,ENST00000403799;;;ENST00000403799	proximal to TCRB	Hyperinsulinemic hypoglycemia, familial, 3	602485	Autosomal dominant	3	Gck
7p13	7:44143213-44189439	GCK, HHF3, PNDM1	Glucokinase (hexokinase-4)	138079	GCK	2645	ENSG00000106633,ENST00000403799;;;ENST00000403799	proximal to TCRB	MODY, type II	125851	Autosomal dominant	3	Gck
7p12.1-q21	7:50500001-98400000	CMH21	Cardiomyopathy, familial hypertrophic, 21	614676		100909387		max lod at D7S669	Cardiomyopathy, hypertrophic, 21	614676	Autosomal dominant	2	
7q21.12	7:87365896-87476027	ABCB4, PGY3, MDR3, ICP3	ATP-binding cassette, subfamily B, member 4 (P-glycoprotein-3/multiple drug resistance-3)	171060	ABCB4	5244	ENSG00000005471,ENST00000649586;;;ENST00000649586	within 500kb of MDR1	Cholestasis, intrahepatic, of pregnancy, 3	614972	Autosomal dominant; Autosomal recessive	3	Abcb4
7q21.12	7:87365896-87476027	ABCB4, PGY3, MDR3, ICP3	ATP-binding cassette, subfamily B, member 4 (P-glycoprotein-3/multiple drug resistance-3)	171060	ABCB4	5244	ENSG00000005471,ENST00000649586;;;ENST00000649586	within 500kb of MDR1	Cholestasis, progressive familial intrahepatic 3	602347	Autosomal recessive	3	Abcb4
7q21.12	7:87365896-87476027	ABCB4, PGY3, MDR3, ICP3	ATP-binding cassette, subfamily B, member 4 (P-glycoprotein-3/multiple drug resistance-3)	171060	ABCB4	5244	ENSG00000005471,ENST00000649586;;;ENST00000649586	within 500kb of MDR1	Gallbladder disease 1	600803	Autosomal dominant; Autosomal recessive	3	Abcb4
7q21.2	7:93099518-93117979	SAMD9, NFTC, MIRAGE, M7MLS2	Sterile alpha motif domain-containing protein 9	610456	SAMD9	54809	ENSG00000205413,ENST00000379958;;;ENST00000379958		MIRAGE syndrome	617053	Autosomal dominant	3	
7q21.2	7:93099518-93117979	SAMD9, NFTC, MIRAGE, M7MLS2	Sterile alpha motif domain-containing protein 9	610456	SAMD9	54809	ENSG00000205413,ENST00000379958;;;ENST00000379958		Monosomy 7 myelodysplasia and leukemia syndrome 2	619041	Autosomal dominant	3	
7q21.2	7:93099518-93117979	SAMD9, NFTC, MIRAGE, M7MLS2	Sterile alpha motif domain-containing protein 9	610456	SAMD9	54809	ENSG00000205413,ENST00000379958;;;ENST00000379958		Tumoral calcinosis, familial, normophosphatemic	610455	Autosomal recessive	3	
7q22.1	7:100720468-100723700	EPO, MVCD2, ECYT5, DBAL	Erythropoietin	133170	EPO	2056	ENSG00000130427,ENST00000252723;;;ENST00000252723	mutation identified in 1 DBAL family	?Diamond-Blackfan anemia-like	617911	Autosomal recessive	3	Epo
7q22.1	7:100720468-100723700	EPO, MVCD2, ECYT5, DBAL	Erythropoietin	133170	EPO	2056	ENSG00000130427,ENST00000252723;;;ENST00000252723	mutation identified in 1 DBAL family	Erythrocytosis, familial, 5	617907	Autosomal dominant	3	Epo
7q22.1	7:100720468-100723700	EPO, MVCD2, ECYT5, DBAL	Erythropoietin	133170	EPO	2056	ENSG00000130427,ENST00000252723;;;ENST00000252723	mutation identified in 1 DBAL family	{Microvascular complications of diabetes 2}	612623		3	Epo
7q22.1	7:103471789-103989658	RELN, RL, LIS2, ETL7	Reelin	600514	RELN	5649	ENSG00000189056,ENST00000428762;;;ENST00000428762		Lissencephaly 2 (Norman-Roberts type)	257320	Autosomal recessive	3	Reln
7q22.1	7:103471789-103989658	RELN, RL, LIS2, ETL7	Reelin	600514	RELN	5649	ENSG00000189056,ENST00000428762;;;ENST00000428762		{Epilepsy, familial temporal lobe, 7}	616436	Autosomal dominant	3	Reln
7q31.2	7:116525009-116561185	CAV1, BSCL3, CGL3, PPH3, LCCNS	Caveolin-1	601047	CAV1	857	ENSG00000105974,ENST00000341049;;;ENST00000341049		Lipodystrophy, congenital generalized, type 3	612526	Autosomal recessive	3	Cav1
7q31.2	7:116525009-116561185	CAV1, BSCL3, CGL3, PPH3, LCCNS	Caveolin-1	601047	CAV1	857	ENSG00000105974,ENST00000341049;;;ENST00000341049		Lipodystrophy, familial partial, type 7	606721	Autosomal dominant	3	Cav1
7q31.2	7:116525009-116561185	CAV1, BSCL3, CGL3, PPH3, LCCNS	Caveolin-1	601047	CAV1	857	ENSG00000105974,ENST00000341049;;;ENST00000341049		Pulmonary hypertension, primary, 3	615343	Autosomal dominant	3	Cav1
7q31.2	7:116672196-116798377	MET, DFNB97, OSFD, DA11	MET protooncogene, receptor tyrosine kinase	164860	MET	4233	ENSG00000105976,ENST00000397752;;;ENST00000397752	mutation identified in 1 DFNB97 family and 1 DA11 family	?Arthrogryposis, distal, type 11	620019	Autosomal dominant	3	Met
7q31.2	7:116672196-116798377	MET, DFNB97, OSFD, DA11	MET protooncogene, receptor tyrosine kinase	164860	MET	4233	ENSG00000105976,ENST00000397752;;;ENST00000397752	mutation identified in 1 DFNB97 family and 1 DA11 family	?Deafness, autosomal recessive 97	616705	Autosomal recessive	3	Met
7q31.2	7:116672196-116798377	MET, DFNB97, OSFD, DA11	MET protooncogene, receptor tyrosine kinase	164860	MET	4233	ENSG00000105976,ENST00000397752;;;ENST00000397752	mutation identified in 1 DFNB97 family and 1 DA11 family	Hepatocellular carcinoma, childhood type, somatic	114550		3	Met
7q31.2	7:116672196-116798377	MET, DFNB97, OSFD, DA11	MET protooncogene, receptor tyrosine kinase	164860	MET	4233	ENSG00000105976,ENST00000397752;;;ENST00000397752	mutation identified in 1 DFNB97 family and 1 DA11 family	Renal cell carcinoma, papillary, 1, familial and somatic	605074		3	Met
7q31.2	7:116672196-116798377	MET, DFNB97, OSFD, DA11	MET protooncogene, receptor tyrosine kinase	164860	MET	4233	ENSG00000105976,ENST00000397752;;;ENST00000397752	mutation identified in 1 DFNB97 family and 1 DA11 family	{Osteofibrous dysplasia, susceptibility to}	607278	Autosomal dominant	3	Met
7q32.1	7:128830406-128859272	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5	Filamin C (actin-binding protein-280)	102565	FLNC	2318	ENSG00000128591,ENST00000325888;;;ENST00000325888		Cardiomyopathy, familial hypertrophic, 26	617047	Autosomal dominant	3	Flnc
7q32.1	7:128830406-128859272	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5	Filamin C (actin-binding protein-280)	102565	FLNC	2318	ENSG00000128591,ENST00000325888;;;ENST00000325888		Cardiomyopathy, familial restrictive 5	617047	Autosomal dominant	3	Flnc
7q32.1	7:128830406-128859272	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5	Filamin C (actin-binding protein-280)	102565	FLNC	2318	ENSG00000128591,ENST00000325888;;;ENST00000325888		Myopathy, distal, 4	614065	Autosomal dominant	3	Flnc
7q32.1	7:128830406-128859272	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5	Filamin C (actin-binding protein-280)	102565	FLNC	2318	ENSG00000128591,ENST00000325888;;;ENST00000325888		Myopathy, myofibrillar, 5	609524	Autosomal dominant	3	Flnc
7q33	7:134646853-134679816	BPGM, ECYT8	2,3-bisphosphoglycerate mutase	613896	BPGM	669	ENSG00000172331,ENST00000344924;;;ENST00000344924		Erythrocytosis, familial, 8	222800	Autosomal recessive	3	Bpgm
7q36.2	7:153748133-154894285	DPP6, VF2, MRD33	Dipeptidylpeptidase VI	126141	DPP6	1804	ENSG00000130226,ENST00000377770;;;ENST00000377770		Intellectual developmental disorder, autosomal dominant 33	616311	Autosomal dominant	3	Dpp6
7q36.2	7:153748133-154894285	DPP6, VF2, MRD33	Dipeptidylpeptidase VI	126141	DPP6	1804	ENSG00000130226,ENST00000377770;;;ENST00000377770		{Ventricular fibrillation, paroxysmal familial, 2}	612956	Autosomal dominant	3	Dpp6
8p21.3	8:19939253-19967259	LPL, LIPD, HDLCQ11	Lipoprotein lipase	609708	LPL	4023	ENSG00000175445,ENST00000650287;;;ENST00000650287		Combined hyperlipidemia, familial	144250	Autosomal dominant	3	Lpl
8p21.3	8:19939253-19967259	LPL, LIPD, HDLCQ11	Lipoprotein lipase	609708	LPL	4023	ENSG00000175445,ENST00000650287;;;ENST00000650287		Lipoprotein lipase deficiency	238600	Autosomal recessive	3	Lpl
8p21.3	8:19939253-19967259	LPL, LIPD, HDLCQ11	Lipoprotein lipase	609708	LPL	4023	ENSG00000175445,ENST00000650287;;;ENST00000650287		[High density lipoprotein cholesterol level QTL 11]	238600	Autosomal recessive	3	Lpl
8p21.2-p21.1	8:27491143-27548626	EPHX2	Epoxide hydrolase 2, cytoplasmic	132811	EPHX2	2053	ENSG00000120915,ENST00000521400;;;ENST00000521400		{Hypercholesterolemia, familial, due to LDLR defect, modifier of}	143890	Autosomal dominant; Autosomal recessive	3	Ephx2
8q13-q21	8:65100001-92300000	FEB1	Febrile seizures, familial, 1	121210		2233			Febrile seizures, familial, 1	121210	Autosomal dominant	2	
8q13.2	8:67422038-67746360	CPA6, CPAH, ETL5, FEB11	Carboxypeptidase A6	609562	CPA6	57094	ENSG00000165078,ENST00000297770;;;ENST00000297770		Epilepsy, familial temporal lobe, 5	614417	Autosomal dominant; Autosomal recessive	3	Cpa6
8q13.2	8:67422038-67746360	CPA6, CPAH, ETL5, FEB11	Carboxypeptidase A6	609562	CPA6	57094	ENSG00000165078,ENST00000297770;;;ENST00000297770		Febrile seizures, familial, 11	614418	Autosomal recessive	3	Cpa6
8q21.11	8:72021250-72090010	TRPA1, ANKTM1, FEPS1	Transient receptor potential cation channel, subfamily A, member 1	604775	TRPA1	8989	ENSG00000104321,ENST00000262209;;;ENST00000262209	mutation identified in 1 FEPS1 family	?Episodic pain syndrome, familial, 1	615040	Autosomal dominant	3	Trpa1
8q24.11-q24.12	8:118131825-118621963	SAMD12	Sterile alpha motif domain containing 12	618073	SAMD12	401474	ENSG00000177570,ENST00000314727;;;ENST00000314727		Epilepsy, familial adult myoclonic, 1	601068	Autosomal dominant	3	Samd12
9p21	9:19900001-33200000	AAA3	Aneurysm, familial abdominal 3	611891		100188857		associated with rs10757278	{Aneurysm, familial abdominal 3}	611891		2	
9p21	9:19900001-33200000	MFT2, TEM	Trichoepithelioma, multiple familial, 2	612099		100188881		max lod at D9S171	Trichoepithelioma, multiple familial, 2	612099		2	
9q21-q22	9:65000001-99800000	ETL4, ETOLM	Epilepsy, familial temporal lobe, 4	611631		100144434		between GATA152H04 and D9S253	Epilepsy, familial temporal lobe, 4	611631	Autosomal dominant	2	
9q21.11	9:69121264-69255208	TJP2, ZO2, PFIC4, FHCA1	Tight junction protein 2	607709	TJP2	9414	ENSG00000119139,ENST00000377245;;;ENST00000377245		Cholestasis, progressive familial intrahepatic 4	615878	Autosomal recessive	3	Tjp2
9q21.11	9:69121264-69255208	TJP2, ZO2, PFIC4, FHCA1	Tight junction protein 2	607709	TJP2	9414	ENSG00000119139,ENST00000377245;;;ENST00000377245		Hypercholanemia, familial 1	607748	Autosomal recessive	3	Tjp2
9q21.3-q22	9:78500001-99800000	FHL1, HPLH1, HLH1	Hemophagocytic lymphohistiocytosis, familial, 1	267700		27259			Hemophagocytic lymphohistiocytosis, familial, 1	267700	Autosomal recessive	2	
9q31.1	9:104781006-104928155	ABCA1, ABC1, HPALP1, TGD, HDLCQTL13	ATP-binding cassette 1	600046	ABCA1	19	ENSG00000165029,ENST00000374736;;;ENST00000374736		HDL deficiency, familial, 1	604091	Autosomal dominant	3	Abca1
9q31.1	9:104781006-104928155	ABCA1, ABC1, HPALP1, TGD, HDLCQTL13	ATP-binding cassette 1	600046	ABCA1	19	ENSG00000165029,ENST00000374736;;;ENST00000374736		Tangier disease	205400	Autosomal recessive	3	Abca1
9q31.3	9:108867517-108934124	ELP1, IKBKAP, IKAP	Elongator complex protein 1	603722	ELP1	8518	ENSG00000070061,ENST00000374647;;;ENST00000374647		Dysautonomia, familial	223900	Autosomal recessive	3	Elp1
9q31.3	9:108867517-108934124	ELP1, IKBKAP, IKAP	Elongator complex protein 1	603722	ELP1	8518	ENSG00000070061,ENST00000374647;;;ENST00000374647		{Medulloblastoma}	155255	Autosomal dominant; Autosomal recessive; Somatic mutation	3	Elp1
9q32	9:114091638-114099292	KIF12, PFIC8	Kinesin family member 12	611278	KIF12	113220	ENSG00000136883,ENST00000640217;;;ENST00000640217		Cholestasis, progressive familial intrahepatic, 8	619662	Autosomal recessive	3	Kif12
10q11.23-q21.1	10:50990888-52298350	PRKG1, PRKG1B, PRKGR1B, AAT8	Protein kinase, cGMP-dependent, regulatory, type I	176894	PRKG1	5592	ENSG00000185532,ENST00000373980;;;ENST00000373980		Aortic aneurysm, familial thoracic 8	615436	Autosomal dominant	3	Prkg1
10q21.3	10:65912523-67763594	CTNNA3, ARVD13	Catenin, alpha-3	607667	CTNNA3	29119	ENSG00000183230,ENST00000433211;;;ENST00000433211		Arrhythmogenic right ventricular dysplasia, familial, 13	615616	Autosomal dominant	3	Ctnna3
10q21.3	10:68087897-68212017	MYPN, CMD1DD, CMH22, RCM4, CMYP24	Myopalladin	608517	MYPN	84665	ENSG00000138347,ENST00000358913;;;ENST00000358913		Cardiomyopathy, dilated, 1KK	615248	Autosomal dominant	3	Mypn
10q21.3	10:68087897-68212017	MYPN, CMD1DD, CMH22, RCM4, CMYP24	Myopalladin	608517	MYPN	84665	ENSG00000138347,ENST00000358913;;;ENST00000358913		Cardiomyopathy, familial restrictive, 4	615248	Autosomal dominant	3	Mypn
10q21.3	10:68087897-68212017	MYPN, CMD1DD, CMH22, RCM4, CMYP24	Myopalladin	608517	MYPN	84665	ENSG00000138347,ENST00000358913;;;ENST00000358913		Cardiomyopathy, hypertrophic, 22	615248	Autosomal dominant	3	Mypn
10q21.3	10:68087897-68212017	MYPN, CMD1DD, CMH22, RCM4, CMYP24	Myopalladin	608517	MYPN	84665	ENSG00000138347,ENST00000358913;;;ENST00000358913		Congenital myopathy 24	617336	Autosomal recessive	3	Mypn
10q22-q24	10:68800001-104000000	ATFB1	Atrial fibrillation, familial, 1	608583		406216			Atrial fibrillation, familial, 1	608583	Autosomal dominant	2	
10q22.1	10:70597348-70602741	PRF1, HPLH2, FLH2	Perforin	170280	PRF1	5551	ENSG00000180644,ENST00000441259;;;ENST00000441259	mistakenly assigned to chr.17	Aplastic anemia	609135		3	Prf1
10q22.1	10:70597348-70602741	PRF1, HPLH2, FLH2	Perforin	170280	PRF1	5551	ENSG00000180644,ENST00000441259;;;ENST00000441259	mistakenly assigned to chr.17	Hemophagocytic lymphohistiocytosis, familial, 2	603553	Autosomal recessive	3	Prf1
10q22.1	10:70597348-70602741	PRF1, HPLH2, FLH2	Perforin	170280	PRF1	5551	ENSG00000180644,ENST00000441259;;;ENST00000441259	mistakenly assigned to chr.17	Lymphoma, non-Hodgkin	605027		3	Prf1
10q23.3	10:87700001-95300000	RCM2	Cardiomyopathy, familial restrictive, 2	609578		619468		max lod at D10S1242	Cardiomyopathy, familial restrictive, 2	609578		2	
10q23.31	10:88935074-88991337	ACTA2, ACTSA, AAT6, MYMY5	Actin, alpha-2, smooth muscle, aorta	102620	ACTA2	59	ENSG00000107796,ENST00000224784;;;ENST00000224784		Aortic aneurysm, familial thoracic 6	611788	Autosomal dominant	3	Acta2
10q23.31	10:88935074-88991337	ACTA2, ACTSA, AAT6, MYMY5	Actin, alpha-2, smooth muscle, aorta	102620	ACTA2	59	ENSG00000107796,ENST00000224784;;;ENST00000224784		Moyamoya disease 5	614042		3	Acta2
10q23.31	10:88935074-88991337	ACTA2, ACTSA, AAT6, MYMY5	Actin, alpha-2, smooth muscle, aorta	102620	ACTA2	59	ENSG00000107796,ENST00000224784;;;ENST00000224784		Multisystemic smooth muscle dysfunction syndrome	613834	Autosomal dominant	3	Acta2
10q23.33	10:93757936-93798159	LGI1, EPT, ETL1, ADLTE, ADPEAF	Leucine-rich gene, glioma-inactivated, 1	604619	LGI1	9211	ENSG00000108231,ENST00000371418;;;ENST00000371418		Epilepsy, familial temporal lobe, 1	600512	Autosomal dominant	3	Lgi1
10q24.32	10:102502819-102633535	SUFU, SUFUXL, SUFUH, JBTS32, BCNS2	Suppressor of fused	607035	SUFU	51684	ENSG00000107882,ENST00000369902;;;ENST00000369902		Basal cell nevus syndrome 2	620343		3	Sufu
10q24.32	10:102502819-102633535	SUFU, SUFUXL, SUFUH, JBTS32, BCNS2	Suppressor of fused	607035	SUFU	51684	ENSG00000107882,ENST00000369902;;;ENST00000369902		Joubert syndrome 32	617757	Autosomal recessive	3	Sufu
10q24.32	10:102502819-102633535	SUFU, SUFUXL, SUFUH, JBTS32, BCNS2	Suppressor of fused	607035	SUFU	51684	ENSG00000107882,ENST00000369902;;;ENST00000369902		{Medulloblastoma}	155255	Autosomal dominant; Autosomal recessive; Somatic mutation	3	Sufu
10q24.32	10:102502819-102633535	SUFU, SUFUXL, SUFUH, JBTS32, BCNS2	Suppressor of fused	607035	SUFU	51684	ENSG00000107882,ENST00000369902;;;ENST00000369902		{Meningioma, familial, susceptibility to}	607174	Autosomal dominant	3	Sufu
10q25.3	10:114043866-114046904	ADRB1, ADRB1R, RHR, FNSS2	Adrenergic, beta-1-, receptor	109630	ADRB1	153	ENSG00000043591,ENST00000369295;;;ENST00000369295	close linkage to ADRA2R	[Resting heart rate]	607276		3	Adrb1
10q25.3	10:114043866-114046904	ADRB1, ADRB1R, RHR, FNSS2	Adrenergic, beta-1-, receptor	109630	ADRB1	153	ENSG00000043591,ENST00000369295;;;ENST00000369295	close linkage to ADRA2R	[Short sleep, familial natural, 2]	618591	Autosomal dominant	3	Adrb1
11p15.5-p15.4	11:2445008-2849105	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	Potassium voltage-gated channel, KQT-like subfamily, member 1	607542	KCNQ1	3784	ENSG00000053918,ENST00000155840;;;ENST00000155840		Atrial fibrillation, familial, 3	607554	Autosomal dominant	3	Kcnq1
11p15.5-p15.4	11:2445008-2849105	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	Potassium voltage-gated channel, KQT-like subfamily, member 1	607542	KCNQ1	3784	ENSG00000053918,ENST00000155840;;;ENST00000155840		Jervell and Lange-Nielsen syndrome	220400	Autosomal recessive	3	Kcnq1
11p15.5-p15.4	11:2445008-2849105	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	Potassium voltage-gated channel, KQT-like subfamily, member 1	607542	KCNQ1	3784	ENSG00000053918,ENST00000155840;;;ENST00000155840		Long QT syndrome 1	192500	Autosomal dominant	3	Kcnq1
11p15.5-p15.4	11:2445008-2849105	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	Potassium voltage-gated channel, KQT-like subfamily, member 1	607542	KCNQ1	3784	ENSG00000053918,ENST00000155840;;;ENST00000155840		Short QT syndrome 2	609621	Autosomal dominant	3	Kcnq1
11p15.5-p15.4	11:2445008-2849105	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	Potassium voltage-gated channel, KQT-like subfamily, member 1	607542	KCNQ1	3784	ENSG00000053918,ENST00000155840;;;ENST00000155840		{Long QT syndrome 1, acquired, susceptibility to}	192500	Autosomal dominant	3	Kcnq1
11p15.3	11:13492054-13496181	PTH, FIH1	Parathyroid hormone	168450	PTH	5741	ENSG00000152266,ENST00000282091;;;ENST00000282091	~9cM distal to CALC1; distal to MYOD	Hypoparathyroidism, familial isolated 1	146200	Autosomal dominant; Autosomal recessive	3	Pth
11p15.1	11:17385248-17389346	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13, PNDM2	Potassium inwardly-rectifying channel, subfamily J, member 11	600937	KCNJ11	3767	ENSG00000187486,ENST00000339994;;;ENST00000339994	4.5kb 3' of SUR	Diabetes mellitus, transient neonatal 3	610582	Autosomal dominant	3	Kcnj11
11p15.1	11:17385248-17389346	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13, PNDM2	Potassium inwardly-rectifying channel, subfamily J, member 11	600937	KCNJ11	3767	ENSG00000187486,ENST00000339994;;;ENST00000339994	4.5kb 3' of SUR	Diabetes, permanent neonatal 2, with or without neurologic features	618856	Autosomal dominant	3	Kcnj11
11p15.1	11:17385248-17389346	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13, PNDM2	Potassium inwardly-rectifying channel, subfamily J, member 11	600937	KCNJ11	3767	ENSG00000187486,ENST00000339994;;;ENST00000339994	4.5kb 3' of SUR	Hyperinsulinemic hypoglycemia, familial, 2	601820	Autosomal dominant; Autosomal recessive	3	Kcnj11
11p15.1	11:17385248-17389346	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13, PNDM2	Potassium inwardly-rectifying channel, subfamily J, member 11	600937	KCNJ11	3767	ENSG00000187486,ENST00000339994;;;ENST00000339994	4.5kb 3' of SUR	Maturity-onset diabetes of the young, type 13	616329	Autosomal dominant	3	Kcnj11
11p15.1	11:17385248-17389346	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13, PNDM2	Potassium inwardly-rectifying channel, subfamily J, member 11	600937	KCNJ11	3767	ENSG00000187486,ENST00000339994;;;ENST00000339994	4.5kb 3' of SUR	{Diabetes mellitus, type 2, susceptibility to}	125853	Autosomal dominant	3	Kcnj11
11p15.1	11:17392498-17476845	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2, PNDM3	ATP-binding cassette, subfamily C, member 8 (sulfonylurea receptor)	600509	ABCC8	6833	ENSG00000006071,ENST00000389817;;;ENST00000389817		Diabetes mellitus, noninsulin-dependent	125853	Autosomal dominant	3	Abcc8
11p15.1	11:17392498-17476845	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2, PNDM3	ATP-binding cassette, subfamily C, member 8 (sulfonylurea receptor)	600509	ABCC8	6833	ENSG00000006071,ENST00000389817;;;ENST00000389817		Diabetes mellitus, permanent neonatal 3, with or without neurologic features	618857	Autosomal dominant; Autosomal recessive	3	Abcc8
11p15.1	11:17392498-17476845	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2, PNDM3	ATP-binding cassette, subfamily C, member 8 (sulfonylurea receptor)	600509	ABCC8	6833	ENSG00000006071,ENST00000389817;;;ENST00000389817		Diabetes mellitus, transient neonatal 2	610374		3	Abcc8
11p15.1	11:17392498-17476845	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2, PNDM3	ATP-binding cassette, subfamily C, member 8 (sulfonylurea receptor)	600509	ABCC8	6833	ENSG00000006071,ENST00000389817;;;ENST00000389817		Hyperinsulinemic hypoglycemia, familial, 1	256450	Autosomal dominant; Autosomal recessive	3	Abcc8
11p15.1	11:17392498-17476845	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2, PNDM3	ATP-binding cassette, subfamily C, member 8 (sulfonylurea receptor)	600509	ABCC8	6833	ENSG00000006071,ENST00000389817;;;ENST00000389817		Hypoglycemia of infancy, leucine-sensitive	240800	Autosomal dominant	3	Abcc8
11p13-q12	11:31000001-63600000	CANDF3, CANDN1, FCNC	Candidiasis, familial, 3	607644		338434		between D11S1312 and D11S4191	Candidiasis, familial, 3	607644	Autosomal dominant	2	
11q13.1	11:65653601-65663857	RELA, NFKB3, CMCU, AIF3BL3	RELA protooncogene, NF-kB subunit	164014	RELA	5970	ENSG00000173039,ENST00000406246;;;ENST00000406246		Autoinflammatory disease, familial, Behcet-like-3	618287	Autosomal dominant	3	Rela
11q13.2	11:68684544-68691175	GAL, GALN, GLNN, ETL8	Galanin	137035	GAL	51083	ENSG00000069482,ENST00000265643;;;ENST00000265643	mutation identified in 1 ETL8 family	?Epilepsy, familial temporal lobe, 8	616461	Autosomal dominant	3	Gal
11q23	11:110600001-121300000	APOGCDS	Familial apolipoprotein gene cluster deletion syndrome	620058					Familial apolipoprotein gene cluster deletion syndrome	620058	Autosomal dominant	4	
11q23.3-q24	11:114600001-130900000	AAT1, FAA1	Aortic aneurysm, familial thoracic 1	607086		252842			Aortic aneurysm, familial thoracic 1	607086		2	
11q23.3	11:118133377-118152823	SCN4B, LQT10, ATFB17	Sodium voltage-gated channel, beta subunit 4	608256	SCN4B	6330	ENSG00000177098,ENST00000324727;;;ENST00000324727		Atrial fibrillation, familial, 17	611819	Autosomal dominant	3	Scn4b
11q23.3	11:118133377-118152823	SCN4B, LQT10, ATFB17	Sodium voltage-gated channel, beta subunit 4	608256	SCN4B	6330	ENSG00000177098,ENST00000324727;;;ENST00000324727		Long QT syndrome 10	611819	Autosomal dominant	3	Scn4b
11q23.3	11:118162806-118176639	SCN2B, ATFB14	Sodium voltage-gated channel, beta subunit 1	601327	SCN2B	6327	ENSG00000149575,ENST00000278947;;;ENST00000278947		Atrial fibrillation, familial, 14	615378	Autosomal dominant	3	Scn2b
11q24.1	11:123629188-123654624	SCN3B, SCNB3, BRGDA7, ATFB16	Sodium voltage-gated channel, beta subunit 3	608214	SCN3B	55800	ENSG00000166257,ENST00000299333;;;ENST00000299333		Atrial fibrillation, familial, 16	613120	Autosomal dominant	3	Scn3b
11q24.1	11:123629188-123654624	SCN3B, SCNB3, BRGDA7, ATFB16	Sodium voltage-gated channel, beta subunit 3	608214	SCN3B	55800	ENSG00000166257,ENST00000299333;;;ENST00000299333		Brugada syndrome 7	613120	Autosomal dominant	3	Scn3b
11q24.2	11:124865432-124881471	ROBO3, RBIG1, RIG1, HGPPS1	Roundabout guidance receptor 3	608630	ROBO3	64221	ENSG00000154134,ENST00000397801;;;ENST00000397801		Gaze palsy, familial horizontal, with progressive scoliosis, 1	607313	Autosomal recessive	3	Robo3
11q24.3	11:128891356-128921163	KCNJ5, GIRK4, KATP1, LQT13	Potassium inwardly-rectifying channel, subfamily J, member 5	600734	KCNJ5	3762	ENSG00000120457,ENST00000529694;;;ENST00000529694		Hyperaldosteronism, familial, type III	613677	Autosomal dominant	3	Kcnj5
11q24.3	11:128891356-128921163	KCNJ5, GIRK4, KATP1, LQT13	Potassium inwardly-rectifying channel, subfamily J, member 5	600734	KCNJ5	3762	ENSG00000120457,ENST00000529694;;;ENST00000529694		Long QT syndrome 13	613485	Autosomal dominant	3	Kcnj5
12p13.32	12:4368227-4379712	FGF23, ADHR, HPDR2, PHPTC, HFTC2	Fibroblast growth factor 23	605380	FGF23	8074	ENSG00000118972,ENST00000237837;;;ENST00000237837		Hypophosphatemic rickets, autosomal dominant	193100	Autosomal dominant	3	Fgf23
12p13.32	12:4368227-4379712	FGF23, ADHR, HPDR2, PHPTC, HFTC2	Fibroblast growth factor 23	605380	FGF23	8074	ENSG00000118972,ENST00000237837;;;ENST00000237837		Tumoral calcinosis, hyperphosphatemic, familial, 2	617993	Autosomal recessive	3	Fgf23
12p13.32	12:5043879-5046788	KCNA5, ATFB7	Potassium voltage-gated channel, shaker-related subfamily, member 5	176267	KCNA5	3741	ENSG00000130037,ENST00000252321;;;ENST00000252321		Atrial fibrillation, familial, 7	612240	Autosomal dominant	3	Kcna5
12p13.31	12:6328771-6342076	TNFRSF1A, TNFR1, TNFAR, FPF, MS5	Tumor necrosis factor receptor superfamily, member 1A	191190	TNFRSF1A	7132	ENSG00000067182,ENST00000162749;;;ENST00000162749		Periodic fever, familial	142680	Autosomal dominant	3	Tnfrsf1a
12p13.31	12:6328771-6342076	TNFRSF1A, TNFR1, TNFAR, FPF, MS5	Tumor necrosis factor receptor superfamily, member 1A	191190	TNFRSF1A	7132	ENSG00000067182,ENST00000162749;;;ENST00000162749		{Multiple sclerosis, susceptibility to, 5}	614810		3	Tnfrsf1a
12p13.31	12:8645943-8662826	MFAP5, MAGP2, AAT9	Microfibril-associated protein 5	601103	MFAP5	8076	ENSG00000197614,ENST00000359478;;;ENST00000359478		Aortic aneurysm, familial thoracic 9	616166	Autosomal dominant	3	Mfap5
12p13.2	12:10116777-10130304	CLEC7A, CLECSF12, DECTIN1, CANDF4	C-type lectin domain family 7, member A	606264	CLEC7A	64581	ENSG00000172243,ENST00000304084;;;ENST00000304084	in natural killer gene complex	Candidiasis, familial, 4, autosomal recessive	613108	Autosomal recessive	3	Clec7a
12p13.2	12:10116777-10130304	CLEC7A, CLECSF12, DECTIN1, CANDF4	C-type lectin domain family 7, member A	606264	CLEC7A	64581	ENSG00000172243,ENST00000304084;;;ENST00000304084	in natural killer gene complex	{Aspergillosis, susceptibility to}	614079		3	Clec7a
12p12.1	12:21797389-21941426	ABCC9, SUR2, CMD1O, ATFB12, CANTU, IDMYS	ATP-binding cassette, subfamily C, member 9 (sulfonylurea receptor 2)	601439	ABCC9	10060	ENSG00000069431,ENST00000261200;;;ENST00000261200	mutation identified in 1 ATFB12 patient	?Atrial fibrillation, familial, 12	614050	Autosomal dominant	3	Abcc9
12p12.1	12:21797389-21941426	ABCC9, SUR2, CMD1O, ATFB12, CANTU, IDMYS	ATP-binding cassette, subfamily C, member 9 (sulfonylurea receptor 2)	601439	ABCC9	10060	ENSG00000069431,ENST00000261200;;;ENST00000261200	mutation identified in 1 ATFB12 patient	Cardiomyopathy, dilated, 1O	608569	Autosomal dominant	3	Abcc9
12p12.1	12:21797389-21941426	ABCC9, SUR2, CMD1O, ATFB12, CANTU, IDMYS	ATP-binding cassette, subfamily C, member 9 (sulfonylurea receptor 2)	601439	ABCC9	10060	ENSG00000069431,ENST00000261200;;;ENST00000261200	mutation identified in 1 ATFB12 patient	Hypertrichotic osteochondrodysplasia (Cantu syndrome)	239850	Autosomal dominant	3	Abcc9
12p12.1	12:21797389-21941426	ABCC9, SUR2, CMD1O, ATFB12, CANTU, IDMYS	ATP-binding cassette, subfamily C, member 9 (sulfonylurea receptor 2)	601439	ABCC9	10060	ENSG00000069431,ENST00000261200;;;ENST00000261200	mutation identified in 1 ATFB12 patient	Intellectual disability and myopathy syndrome	619719	Autosomal recessive	3	Abcc9
12p12.1	12:26120030-26125037	BHLHE41, BHLHB3, DEC2, SHARP1, FNSS1	Basic helix-loop-helix domain-containing protein, member E41	606200	BHLHE41	79365	ENSG00000123095,ENST00000242728;;;ENST00000242728		[Short sleep, familial natural, 1]	612975	Autosomal dominant	3	Bhlhe41
12p11.23-q13.12	12:26300001-51100000	AD5	Alzheimer disease, familial, type 5	602096		8081			Alzheimer disease-5	602096	Autosomal dominant	2	
12q13.13	12:51591233-51812864	SCN8A, CIAT, DEE13, BFIS5, MYOCL2	Sodium voltage-gated channel, alpha subunit 8	600702	SCN8A	6334	ENSG00000196876,ENST00000627620;;;ENST00000627620	mutation identified in 1 MYOCL2 family	?Myoclonus, familial, 2	618364	Autosomal dominant	3	Scn8a
12q13.13	12:51591233-51812864	SCN8A, CIAT, DEE13, BFIS5, MYOCL2	Sodium voltage-gated channel, alpha subunit 8	600702	SCN8A	6334	ENSG00000196876,ENST00000627620;;;ENST00000627620	mutation identified in 1 MYOCL2 family	Cognitive impairment with or without cerebellar ataxia	614306	Autosomal dominant	3	Scn8a
12q13.13	12:51591233-51812864	SCN8A, CIAT, DEE13, BFIS5, MYOCL2	Sodium voltage-gated channel, alpha subunit 8	600702	SCN8A	6334	ENSG00000196876,ENST00000627620;;;ENST00000627620	mutation identified in 1 MYOCL2 family	Developmental and epileptic encephalopathy 13	614558	Autosomal dominant	3	Scn8a
12q13.13	12:51591233-51812864	SCN8A, CIAT, DEE13, BFIS5, MYOCL2	Sodium voltage-gated channel, alpha subunit 8	600702	SCN8A	6334	ENSG00000196876,ENST00000627620;;;ENST00000627620	mutation identified in 1 MYOCL2 family	Seizures, benign familial infantile, 5	617080	Autosomal dominant	3	Scn8a
12q13.2	12:56080108-56103505	ERBB3, LCCS2, FERLK, VSCN1	Transformation gene ERBB-3	190151	ERBB3	2065	ENSG00000065361,ENST00000267101;;;ENST00000267101	mutations identified in 1 LCCS2 family and 1 FERLK family	?Lethal congenital contractural syndrome 2	607598	Autosomal recessive	3	Erbb3
12q13.2	12:56080108-56103505	ERBB3, LCCS2, FERLK, VSCN1	Transformation gene ERBB-3	190151	ERBB3	2065	ENSG00000065361,ENST00000267101;;;ENST00000267101	mutations identified in 1 LCCS2 family and 1 FERLK family	Visceral neuropathy, familial, 1, autosomal recessive	243180	Autosomal recessive	3	Erbb3
12q13.2	12:56080108-56103505	ERBB3, LCCS2, FERLK, VSCN1	Transformation gene ERBB-3	190151	ERBB3	2065	ENSG00000065361,ENST00000267101;;;ENST00000267101	mutations identified in 1 LCCS2 family and 1 FERLK family	{?Erythroleukemia, familial, susceptibility to}	133180	Autosomal dominant	3	Erbb3
12q13.3	12:56200001-57700000	AAA4	Aortic aneurysm, familial abdominal, 4	614375		100859927		associated with rs1466535	Aortic aneurysm, familial abdominal, 4	614375		2	
12q13.3	12:56416363-56449426	TIMELESS, TIM, TIM1, FASPS4	Timeless circadian regulator	603887	TIMELESS	8914	ENSG00000111602,ENST00000553532;;;ENST00000553532	mutation identified in 1 FASPS4 family	?Advance sleep phase syndrome, familial, 4	620015	Autosomal dominant	3	Timeless
12q22-q23.3	12:92200001-108600000	ETL2, FTLE	Epilepsy, familial temporal lobe	608096		619399		max lod at D12S1706	Epilepsy, familial temporal lobe, 2	608096	Autosomal dominant	2	
12q23.1	12:100473866-100564414	NR1H4, FXR, RIP14, PFIC5	Nuclear receptor subfamily 1 group H member 4	603826	NR1H4	9971	ENSG00000012504,ENST00000392986;;;ENST00000392986		Cholestasis, progressive familial intrahepatic, 5	617049	Autosomal recessive	3	Nr1h4
12q24.1	12:108600001-113900000	STUT2	Stuttering, familial persistent, 2	609261		100049543		max lod with PAH	Stuttering, familial persistent, 2	609261		2	
12q24.11	12:109783087-109833398	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	Transient receptor potential cation channel, subfamily V, member 4 (vanilloid receptor-related osmotically activated channel)	605427	TRPV4	59341	ENSG00000111199,ENST00000261740;;;ENST00000261740	mutation identified in 1 ANFH2 family	?Avascular necrosis of femoral head, primary, 2	617383	Autosomal dominant	3	Trpv4
12q24.11	12:109783087-109833398	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	Transient receptor potential cation channel, subfamily V, member 4 (vanilloid receptor-related osmotically activated channel)	605427	TRPV4	59341	ENSG00000111199,ENST00000261740;;;ENST00000261740	mutation identified in 1 ANFH2 family	Brachyolmia type 3	113500	Autosomal dominant	3	Trpv4
12q24.11	12:109783087-109833398	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	Transient receptor potential cation channel, subfamily V, member 4 (vanilloid receptor-related osmotically activated channel)	605427	TRPV4	59341	ENSG00000111199,ENST00000261740;;;ENST00000261740	mutation identified in 1 ANFH2 family	Digital arthropathy-brachydactyly, familial	606835	Autosomal dominant	3	Trpv4
12q24.11	12:109783087-109833398	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	Transient receptor potential cation channel, subfamily V, member 4 (vanilloid receptor-related osmotically activated channel)	605427	TRPV4	59341	ENSG00000111199,ENST00000261740;;;ENST00000261740	mutation identified in 1 ANFH2 family	Hereditary motor and sensory neuropathy, type IIc	606071	Autosomal dominant	3	Trpv4
12q24.11	12:109783087-109833398	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	Transient receptor potential cation channel, subfamily V, member 4 (vanilloid receptor-related osmotically activated channel)	605427	TRPV4	59341	ENSG00000111199,ENST00000261740;;;ENST00000261740	mutation identified in 1 ANFH2 family	Metatropic dysplasia	156530	Autosomal dominant	3	Trpv4
12q24.11	12:109783087-109833398	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	Transient receptor potential cation channel, subfamily V, member 4 (vanilloid receptor-related osmotically activated channel)	605427	TRPV4	59341	ENSG00000111199,ENST00000261740;;;ENST00000261740	mutation identified in 1 ANFH2 family	Neuronopathy, distal hereditary motor, type VIII	600175	Autosomal dominant	3	Trpv4
12q24.11	12:109783087-109833398	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	Transient receptor potential cation channel, subfamily V, member 4 (vanilloid receptor-related osmotically activated channel)	605427	TRPV4	59341	ENSG00000111199,ENST00000261740;;;ENST00000261740	mutation identified in 1 ANFH2 family	Parastremmatic dwarfism	168400	Autosomal dominant	3	Trpv4
12q24.11	12:109783087-109833398	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	Transient receptor potential cation channel, subfamily V, member 4 (vanilloid receptor-related osmotically activated channel)	605427	TRPV4	59341	ENSG00000111199,ENST00000261740;;;ENST00000261740	mutation identified in 1 ANFH2 family	Scapuloperoneal spinal muscular atrophy	181405	Autosomal dominant	3	Trpv4
12q24.11	12:109783087-109833398	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	Transient receptor potential cation channel, subfamily V, member 4 (vanilloid receptor-related osmotically activated channel)	605427	TRPV4	59341	ENSG00000111199,ENST00000261740;;;ENST00000261740	mutation identified in 1 ANFH2 family	SED, Maroteaux type	184095	Autosomal dominant	3	Trpv4
12q24.11	12:109783087-109833398	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	Transient receptor potential cation channel, subfamily V, member 4 (vanilloid receptor-related osmotically activated channel)	605427	TRPV4	59341	ENSG00000111199,ENST00000261740;;;ENST00000261740	mutation identified in 1 ANFH2 family	Spondylometaphyseal dysplasia, Kozlowski type	184252	Autosomal dominant	3	Trpv4
12q24.11	12:109783087-109833398	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	Transient receptor potential cation channel, subfamily V, member 4 (vanilloid receptor-related osmotically activated channel)	605427	TRPV4	59341	ENSG00000111199,ENST00000261740;;;ENST00000261740	mutation identified in 1 ANFH2 family	[Sodium serum level QTL 1]	613508		3	Trpv4
13q13.1	13:32315508-32400268	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	BRCA2 DNA repair-associated protein	600185	BRCA2	675	ENSG00000139618,ENST00000380152;;;ENST00000380152		Fanconi anemia, complementation group D1	605724	Autosomal recessive	3	Brca2
13q13.1	13:32315508-32400268	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	BRCA2 DNA repair-associated protein	600185	BRCA2	675	ENSG00000139618,ENST00000380152;;;ENST00000380152		Wilms tumor	194070	Autosomal dominant; Somatic mutation	3	Brca2
13q13.1	13:32315508-32400268	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	BRCA2 DNA repair-associated protein	600185	BRCA2	675	ENSG00000139618,ENST00000380152;;;ENST00000380152		{Breast cancer, male, susceptibility to}	114480	Autosomal dominant; Somatic mutation	3	Brca2
13q13.1	13:32315508-32400268	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	BRCA2 DNA repair-associated protein	600185	BRCA2	675	ENSG00000139618,ENST00000380152;;;ENST00000380152		{Breast-ovarian cancer, familial, 2}	612555	Autosomal dominant	3	Brca2
13q13.1	13:32315508-32400268	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	BRCA2 DNA repair-associated protein	600185	BRCA2	675	ENSG00000139618,ENST00000380152;;;ENST00000380152		{Glioblastoma 3}	613029	Autosomal recessive	3	Brca2
13q13.1	13:32315508-32400268	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	BRCA2 DNA repair-associated protein	600185	BRCA2	675	ENSG00000139618,ENST00000380152;;;ENST00000380152		{Medulloblastoma}	155255	Autosomal dominant; Autosomal recessive; Somatic mutation	3	Brca2
13q13.1	13:32315508-32400268	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	BRCA2 DNA repair-associated protein	600185	BRCA2	675	ENSG00000139618,ENST00000380152;;;ENST00000380152		{Pancreatic cancer 2}	613347		3	Brca2
13q13.1	13:32315508-32400268	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	BRCA2 DNA repair-associated protein	600185	BRCA2	675	ENSG00000139618,ENST00000380152;;;ENST00000380152		{Prostate cancer}	176807	Autosomal dominant; Somatic mutation	3	Brca2
13q13.1	13:33016243-33066143	KL, KLOTHO, HFTC3	Klotho	604824	KL	9365	ENSG00000133116,ENST00000380099;;;ENST00000380099	mutation identified in 1 HFTC3 patient	?Tumoral calcinosis, hyperphosphatemic, familial, 3	617994	Autosomal recessive	3	Kl
13q14.2	13:48233206-48270357	ITM2B, BRI, ABRI, FBD, RDGCA	Integral membrane protein 2B (BRI gene)	603904	ITM2B	9445	ENSG00000136156,ENST00000647800;;;ENST00000647800	mutation identified in 1 RDGCA family	?Retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities	616079	Autosomal dominant	3	Itm2b
13q14.2	13:48233206-48270357	ITM2B, BRI, ABRI, FBD, RDGCA	Integral membrane protein 2B (BRI gene)	603904	ITM2B	9445	ENSG00000136156,ENST00000647800;;;ENST00000647800	mutation identified in 1 RDGCA family	Dementia, familial British	176500	Autosomal dominant	3	Itm2b
13q14.2	13:48233206-48270357	ITM2B, BRI, ABRI, FBD, RDGCA	Integral membrane protein 2B (BRI gene)	603904	ITM2B	9445	ENSG00000136156,ENST00000647800;;;ENST00000647800	mutation identified in 1 RDGCA family	Dementia, familial Danish	117300	Autosomal dominant	3	Itm2b
14q24.1	14:69775416-69797241	SLC10A1, NTCP1, FHCA2	Solute carrier family 10 (sodium/bile acid cotransporter family), member 1	182396	SLC10A1	6554	ENSG00000100652,ENST00000216540;;;ENST00000216540		Hypercholanemia, familial 2	619256	Autosomal recessive	3	Slc10a1
14q24.2	14:73136417-73223691	PSEN1, AD3, ACNINV3	Presenilin 1	104311	PSEN1	5663	ENSG00000080815,ENST00000324501;;;ENST00000324501	mutation identified in 1 ACNINV3 family	?Acne inversa, familial, 3	613737	Autosomal dominant	3	Psen1
14q24.2	14:73136417-73223691	PSEN1, AD3, ACNINV3	Presenilin 1	104311	PSEN1	5663	ENSG00000080815,ENST00000324501;;;ENST00000324501	mutation identified in 1 ACNINV3 family	Alzheimer disease, type 3	607822	Autosomal dominant	3	Psen1
14q24.2	14:73136417-73223691	PSEN1, AD3, ACNINV3	Presenilin 1	104311	PSEN1	5663	ENSG00000080815,ENST00000324501;;;ENST00000324501	mutation identified in 1 ACNINV3 family	Alzheimer disease, type 3, with spastic paraparesis and apraxia	607822	Autosomal dominant	3	Psen1
14q24.2	14:73136417-73223691	PSEN1, AD3, ACNINV3	Presenilin 1	104311	PSEN1	5663	ENSG00000080815,ENST00000324501;;;ENST00000324501	mutation identified in 1 ACNINV3 family	Alzheimer disease, type 3, with spastic paraparesis and unusual plaques	607822	Autosomal dominant	3	Psen1
14q24.2	14:73136417-73223691	PSEN1, AD3, ACNINV3	Presenilin 1	104311	PSEN1	5663	ENSG00000080815,ENST00000324501;;;ENST00000324501	mutation identified in 1 ACNINV3 family	Cardiomyopathy, dilated, 1U	613694	Autosomal dominant	3	Psen1
14q24.2	14:73136417-73223691	PSEN1, AD3, ACNINV3	Presenilin 1	104311	PSEN1	5663	ENSG00000080815,ENST00000324501;;;ENST00000324501	mutation identified in 1 ACNINV3 family	Dementia, frontotemporal	600274	Autosomal dominant	3	Psen1
14q24.2	14:73136417-73223691	PSEN1, AD3, ACNINV3	Presenilin 1	104311	PSEN1	5663	ENSG00000080815,ENST00000324501;;;ENST00000324501	mutation identified in 1 ACNINV3 family	Pick disease	172700	Autosomal dominant	3	Psen1
14q31.1	14:80955621-81146306	TSHR, CHNG1	Thyroid-stimulating hormone receptor	603372	TSHR	7253	ENSG00000165409,ENST00000298171;;;ENST00000298171		Hyperthyroidism, familial gestational	603373	Autosomal dominant	3	Tshr
14q31.1	14:80955621-81146306	TSHR, CHNG1	Thyroid-stimulating hormone receptor	603372	TSHR	7253	ENSG00000165409,ENST00000298171;;;ENST00000298171		Hyperthyroidism, nonautoimmune	609152	Autosomal dominant	3	Tshr
14q31.1	14:80955621-81146306	TSHR, CHNG1	Thyroid-stimulating hormone receptor	603372	TSHR	7253	ENSG00000165409,ENST00000298171;;;ENST00000298171		Hypothyroidism, congenital, nongoitrous, 1	275200	Autosomal recessive	3	Tshr
14q31.1	14:80955621-81146306	TSHR, CHNG1	Thyroid-stimulating hormone receptor	603372	TSHR	7253	ENSG00000165409,ENST00000298171;;;ENST00000298171		Thyroid adenoma, hyperfunctioning, somatic			3	Tshr
14q31.1	14:80955621-81146306	TSHR, CHNG1	Thyroid-stimulating hormone receptor	603372	TSHR	7253	ENSG00000165409,ENST00000298171;;;ENST00000298171		Thyroid carcinoma with thyrotoxicosis, somatic			3	Tshr
14q32	14:89300001-107043718	DUP14q32, C14DUPq32	Chromosome 14q32 duplication syndrome, 700kB	616604				heterozygous germline duplication of 700kb	{Myeloproliferative neoplasms, familial, susceptibility to}	616604	Autosomal dominant	4	
15q15.1	15:40807089-40815084	ZFYVE19, ANCHR, PFIC9	Zinc finger FYVE domain-containing protein 19	619635	ZFYVE19	84936	ENSG00000166140,ENST00000355341;;;ENST00000355341		Cholestasis, progressive familial intrahepatic, 9	619849	Autosomal recessive	3	Zfyve19
15q21.1	15:44711517-44718145	B2M, IMD43	Beta-2-microglobulin	109700	B2M	567	ENSG00000166710,ENST00000648006;;;ENST00000648006	mutation identified in 1 FVA family	?Amyloidosis, familial visceral	105200	Autosomal dominant	3	B2m
15q21.1	15:44711517-44718145	B2M, IMD43	Beta-2-microglobulin	109700	B2M	567	ENSG00000166710,ENST00000648006;;;ENST00000648006	mutation identified in 1 FVA family	Immunodeficiency 43	241600	Autosomal recessive	3	B2m
15q21.1	15:48408313-48645709	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	Fibrillin-1	134797	FBN1	2200	ENSG00000166147,ENST00000316623;;;ENST00000316623		Acromicric dysplasia	102370	Autosomal dominant	3	Fbn1
15q21.1	15:48408313-48645709	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	Fibrillin-1	134797	FBN1	2200	ENSG00000166147,ENST00000316623;;;ENST00000316623		Ectopia lentis, familial	129600	Autosomal dominant	3	Fbn1
15q21.1	15:48408313-48645709	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	Fibrillin-1	134797	FBN1	2200	ENSG00000166147,ENST00000316623;;;ENST00000316623		Geleophysic dysplasia 2	614185	Autosomal dominant	3	Fbn1
15q21.1	15:48408313-48645709	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	Fibrillin-1	134797	FBN1	2200	ENSG00000166147,ENST00000316623;;;ENST00000316623		Marfan lipodystrophy syndrome	616914	Autosomal dominant	3	Fbn1
15q21.1	15:48408313-48645709	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	Fibrillin-1	134797	FBN1	2200	ENSG00000166147,ENST00000316623;;;ENST00000316623		Marfan syndrome	154700	Autosomal dominant	3	Fbn1
15q21.1	15:48408313-48645709	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	Fibrillin-1	134797	FBN1	2200	ENSG00000166147,ENST00000316623;;;ENST00000316623		MASS syndrome	604308	Autosomal dominant	3	Fbn1
15q21.1	15:48408313-48645709	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	Fibrillin-1	134797	FBN1	2200	ENSG00000166147,ENST00000316623;;;ENST00000316623		Stiff skin syndrome	184900	Autosomal dominant	3	Fbn1
15q21.1	15:48408313-48645709	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	Fibrillin-1	134797	FBN1	2200	ENSG00000166147,ENST00000316623;;;ENST00000316623		Weill-Marchesani syndrome 2, dominant	608328	Autosomal dominant	3	Fbn1
15q21.2	15:50907492-51005895	AP4E1, SPG51, CPSQ4, STUT1	Adaptor-related protein complex 4, epsilon-1 subunit	607244	AP4E1	23431	ENSG00000081014,ENST00000261842;;;ENST00000261842		Spastic paraplegia 51, autosomal recessive	613744	Autosomal recessive	3	Ap4e1
15q21.2	15:50907492-51005895	AP4E1, SPG51, CPSQ4, STUT1	Adaptor-related protein complex 4, epsilon-1 subunit	607244	AP4E1	23431	ENSG00000081014,ENST00000261842;;;ENST00000261842		Stuttering, familial persistent, 1	184450	Autosomal dominant	3	Ap4e1
15q23	15:71096894-71783383	THSD4, ADAMTSL6, AAT12	Thrombospondin type-1 domain-containing 4	614476	THSD4	79875	ENSG00000187720,ENST00000261862;;;ENST00000261862		Aortic aneurysm, familial thoracic 12	619825	Autosomal dominant	3	Thsd4
15q24.1	15:74409289-74433958	SEMA7A, SEMAL, SEMAK1, CDW108, JMH, PFIC11	Semaphorin 7A	607961	SEMA7A	8482	ENSG00000138623,ENST00000261918;;;ENST00000261918	mutation identified in 1 PFIC11 patient	?Cholestasis, progressive familial intrahepatic, 11	619874	Autosomal recessive	3	Sema7a
15q24.1	15:74409289-74433958	SEMA7A, SEMAL, SEMAK1, CDW108, JMH, PFIC11	Semaphorin 7A	607961	SEMA7A	8482	ENSG00000138623,ENST00000261918;;;ENST00000261918	mutation identified in 1 PFIC11 patient	[Blood group, John-Milton-Hagen system]	614745		3	Sema7a
15q25.3	15:84817356-84873479	ALPK3, MIDORI, KIAA1330, CMH27	Alpha kinase 3	617608	ALPK3	57538	ENSG00000136383,ENST00000258888;;;ENST00000258888		Cardiomyopathy, familial hypertrophic 27	618052	Autosomal recessive	3	Alpk3
15q26	15:88500001-101991189	VVS	Syncope, familial vasovagal	609289		105031671			Syncope, familial vasovagal	609289	Autosomal dominant	2	
15q26.1	15:89664367-89679367	PLIN1, PLIN, FPLD4	Perilipin 1	170290	PLIN1	5346	ENSG00000166819,ENST00000300055;;;ENST00000300055		Lipodystrophy, familial partial, type 4	613877	Autosomal dominant	3	Plin1
15q26.1	15:90998416-91022621	VPS33B, KDIDAR, PFIC12	VPS33B late endosome and lysosome associated	608552	VPS33B	26276	ENSG00000184056,ENST00000333371;;;ENST00000333371		Arthrogryposis, renal dysfunction, and cholestasis 1	208085	Autosomal recessive	3	Vps33b
15q26.1	15:90998416-91022621	VPS33B, KDIDAR, PFIC12	VPS33B late endosome and lysosome associated	608552	VPS33B	26276	ENSG00000184056,ENST00000333371;;;ENST00000333371		Cholestasis, progressive familial intrahepatic, 12	620010	Autosomal recessive	3	Vps33b
15q26.1	15:90998416-91022621	VPS33B, KDIDAR, PFIC12	VPS33B late endosome and lysosome associated	608552	VPS33B	26276	ENSG00000184056,ENST00000333371;;;ENST00000333371		Keratoderma-ichthyosis-deafness syndrome, autosomal recessive	620009	Autosomal recessive	3	Vps33b
16p13.3	16:85386-138673	NPRL3, CGTHBA, FFEVF3	Nitrogen permease regulator-like 3	600928	NPRL3	8131	ENSG00000103148,ENST00000611875;;;ENST00000611875		Epilepsy, familial focal, with variable foci 3	617118	Autosomal dominant	3	Nprl3
16p13.3	16:1153106-1221768	CACNA1H, EIG6, ECA6, HALD4	Calcium channel, voltage-dependent, T type, alpha-1H subunit	607904	CACNA1H	8912	ENSG00000196557,ENST00000348261;;;ENST00000348261		Hyperaldosteronism, familial, type IV	617027	Autosomal dominant	3	Cacna1h
16p13.3	16:1153106-1221768	CACNA1H, EIG6, ECA6, HALD4	Calcium channel, voltage-dependent, T type, alpha-1H subunit	607904	CACNA1H	8912	ENSG00000196557,ENST00000348261;;;ENST00000348261		{Epilepsy, childhood absence, susceptibility to, 6}	611942		3	Cacna1h
16p13.3	16:1153106-1221768	CACNA1H, EIG6, ECA6, HALD4	Calcium channel, voltage-dependent, T type, alpha-1H subunit	607904	CACNA1H	8912	ENSG00000196557,ENST00000348261;;;ENST00000348261		{Epilepsy, idiopathic generalized, susceptibility to, 6}	611942		3	Cacna1h
16p13.3	16:2039820-2047834	NTHL1, OCTS3, FAP3	Endonuclease III, E. coli, homolog of	602656	NTHL1	4913	ENSG00000065057,ENST00000651570;;;ENST00000651570		Familial adenomatous polyposis 3	616415	Autosomal recessive	3	Nthl1
16p13.3	16:2475127-2505730	TBC1D24, KIAA1171, FIME, DEE16, DOORS, DFNB86, DFNA65, EPRPDC	TBC1 domain family, member 24	613577	TBC1D24	57465	ENSG00000162065,ENST00000646147;;;ENST00000646147		Deafness, autosomal dominant 65	616044	Autosomal dominant	3	Tbc1d24
16p13.3	16:2475127-2505730	TBC1D24, KIAA1171, FIME, DEE16, DOORS, DFNB86, DFNA65, EPRPDC	TBC1 domain family, member 24	613577	TBC1D24	57465	ENSG00000162065,ENST00000646147;;;ENST00000646147		Deafness, autosomal recessive 86	614617	Autosomal recessive	3	Tbc1d24
16p13.3	16:2475127-2505730	TBC1D24, KIAA1171, FIME, DEE16, DOORS, DFNB86, DFNA65, EPRPDC	TBC1 domain family, member 24	613577	TBC1D24	57465	ENSG00000162065,ENST00000646147;;;ENST00000646147		Developmental and epileptic encephalopathy 16	615338	Autosomal recessive	3	Tbc1d24
16p13.3	16:2475127-2505730	TBC1D24, KIAA1171, FIME, DEE16, DOORS, DFNB86, DFNA65, EPRPDC	TBC1 domain family, member 24	613577	TBC1D24	57465	ENSG00000162065,ENST00000646147;;;ENST00000646147		DOORS syndrome	220500	Autosomal recessive	3	Tbc1d24
16p13.3	16:2475127-2505730	TBC1D24, KIAA1171, FIME, DEE16, DOORS, DFNB86, DFNA65, EPRPDC	TBC1 domain family, member 24	613577	TBC1D24	57465	ENSG00000162065,ENST00000646147;;;ENST00000646147		Epilepsy, rolandic, with paroxysmal exercise-induce dystonia and writer's cramp	608105	Autosomal recessive	3	Tbc1d24
16p13.3	16:2475127-2505730	TBC1D24, KIAA1171, FIME, DEE16, DOORS, DFNB86, DFNA65, EPRPDC	TBC1 domain family, member 24	613577	TBC1D24	57465	ENSG00000162065,ENST00000646147;;;ENST00000646147		Myoclonic epilepsy, infantile, familial	605021	Autosomal recessive	3	Tbc1d24
16p13.3	16:3242027-3256633	MEFV, MEF, FMF, PAAND	MEFV innate immunity regulator, pyrin	608107	MEFV	4210	ENSG00000103313,ENST00000219596;;;ENST00000219596	between D16S80 and D16S283	Familial Mediterranean fever, AD	134610	Autosomal dominant	3	Mefv
16p13.3	16:3242027-3256633	MEFV, MEF, FMF, PAAND	MEFV innate immunity regulator, pyrin	608107	MEFV	4210	ENSG00000103313,ENST00000219596;;;ENST00000219596	between D16S80 and D16S283	Familial Mediterranean fever, AR	249100	Autosomal recessive	3	Mefv
16p13.3	16:3242027-3256633	MEFV, MEF, FMF, PAAND	MEFV innate immunity regulator, pyrin	608107	MEFV	4210	ENSG00000103313,ENST00000219596;;;ENST00000219596	between D16S80 and D16S283	Neutrophilic dermatosis, acute febrile	608068	Autosomal dominant	3	Mefv
16p13.13	16:11254417-11256204	SOCS1, SSI1, CIS1, CISH1, AISIMD	Suppressor of cytokine signaling 1	603597	SOCS1	8651	ENSG00000185338,ENST00000332029;;;ENST00000332029		Autoinflammatory syndrome, familial, with or without immunodeficiency	619375	Autosomal dominant	3	Socs1
16p13.11	16:15703135-15857028	MYH11, AAT4, FAA4, VSCM2	Myosin, heavy polypeptide-11, smooth muscle	160745	MYH11	4629	ENSG00000133392,ENST00000300036;;;ENST00000300036	fused with CBFB by inversion in acute myelomonocytic leukemia	Aortic aneurysm, familial thoracic 4	132900	Autosomal dominant	3	Myh11
16p13.11	16:15703135-15857028	MYH11, AAT4, FAA4, VSCM2	Myosin, heavy polypeptide-11, smooth muscle	160745	MYH11	4629	ENSG00000133392,ENST00000300036;;;ENST00000300036	fused with CBFB by inversion in acute myelomonocytic leukemia	Megacystis-microcolon-intestinal hypoperistalsis syndrome 2	619351	Autosomal recessive	3	Myh11
16p13.11	16:15703135-15857028	MYH11, AAT4, FAA4, VSCM2	Myosin, heavy polypeptide-11, smooth muscle	160745	MYH11	4629	ENSG00000133392,ENST00000300036;;;ENST00000300036	fused with CBFB by inversion in acute myelomonocytic leukemia	Visceral myopathy 2	619350	Autosomal dominant	3	Myh11
16p12.1	16:24610205-24826218	TNRC6A, GW182, KIAA1460, FAME6	Trinucleotide repeat-containing gene 6A	610739	TNRC6A	27327	ENSG00000090905,ENST00000395799;;;ENST00000395799	mutation identified in 1 FAME6 family	?Epilepsy, familial adult myoclonic, 6	618074	Autosomal dominant	3	Tnrc6a
16p11.2	16:29812193-29815881	PRRT2, PKC, DYT10, EKD1, BFIS2, BFIC2, ICCA	Proline-rich transmembrane protein 2	614386	PRRT2	112476	ENSG00000167371,ENST00000358758;;;ENST00000358758		Convulsions, familial infantile, with paroxysmal choreoathetosis	602066	Autosomal dominant	3	Prrt2
16p11.2	16:29812193-29815881	PRRT2, PKC, DYT10, EKD1, BFIS2, BFIC2, ICCA	Proline-rich transmembrane protein 2	614386	PRRT2	112476	ENSG00000167371,ENST00000358758;;;ENST00000358758		Episodic kinesigenic dyskinesia 1	128200	Autosomal dominant	3	Prrt2
16p11.2	16:29812193-29815881	PRRT2, PKC, DYT10, EKD1, BFIS2, BFIC2, ICCA	Proline-rich transmembrane protein 2	614386	PRRT2	112476	ENSG00000167371,ENST00000358758;;;ENST00000358758		Seizures, benign familial infantile, 2	605751	Autosomal dominant	3	Prrt2
16q12.1-q23.1	16:47000001-79200000	STUT4	Stuttering, familial persistent, 4	614668		100909385		max lod at D16S3043	Stuttering, familial persistent, 4	614668		2	
16q12.1	16:50742086-50801935	CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS, FTDALS8	CYLD lysine-63 deubiquitinase	605018	CYLD	1540	ENSG00000083799,ENST00000427738;;;ENST00000427738	mutation identified in 1 FTDALS8 family	?Frontotemporal dementia and/or amyotrophic lateral sclerosis 8	619132	Autosomal dominant	3	Cyld
16q12.1	16:50742086-50801935	CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS, FTDALS8	CYLD lysine-63 deubiquitinase	605018	CYLD	1540	ENSG00000083799,ENST00000427738;;;ENST00000427738	mutation identified in 1 FTDALS8 family	Brooke-Spiegler syndrome	605041	Autosomal dominant	3	Cyld
16q12.1	16:50742086-50801935	CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS, FTDALS8	CYLD lysine-63 deubiquitinase	605018	CYLD	1540	ENSG00000083799,ENST00000427738;;;ENST00000427738	mutation identified in 1 FTDALS8 family	Cylindromatosis, familial	132700	Autosomal dominant	3	Cyld
16q12.1	16:50742086-50801935	CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS, FTDALS8	CYLD lysine-63 deubiquitinase	605018	CYLD	1540	ENSG00000083799,ENST00000427738;;;ENST00000427738	mutation identified in 1 FTDALS8 family	Trichoepithelioma, multiple familial, 1	601606	Autosomal dominant	3	Cyld
16q22	16:66600001-74100000	ATFB8	Atrial fibrillation, familial, 8	613055		100306979		associated with rs7193343	Atrial fibrillation, familial, 8	613055		2	
16q22.1	16:67170538-67175737	NOL3, NOP, MYC, ARC, FCM, MYOCL1	Nucleolar protein 3	605235	NOL3	8996	ENSG00000140939,ENST00000568146	mutation identified in 1 MYOCL1 family	?Myoclonus, familial, 1	614937	Autosomal dominant	3	Nol3
16q23.3	16:81779291-81962685	PLCG2, FCAS3, APLAID	Phospholipase C, gamma 2	600220	PLCG2	5336	ENSG00000197943,ENST00000564138;;;ENST00000564138		Autoinflammation, antibody deficiency, and immune dysregulation syndrome	614878	Autosomal dominant	3	Plcg2
16q23.3	16:81779291-81962685	PLCG2, FCAS3, APLAID	Phospholipase C, gamma 2	600220	PLCG2	5336	ENSG00000197943,ENST00000564138;;;ENST00000564138		Familial cold autoinflammatory syndrome 3	614468	Autosomal dominant	3	Plcg2
17q11.2	17:31094927-31377677	NF1, VRNF, WSS, NFNS	Neurofibromin (neurofibromatosis, type I)	613113	NF1	4763	ENSG00000196712,ENST00000358273;;;ENST00000358273		Leukemia, juvenile myelomonocytic	607785	Autosomal dominant; Somatic mutation	3	Nf1
17q11.2	17:31094927-31377677	NF1, VRNF, WSS, NFNS	Neurofibromin (neurofibromatosis, type I)	613113	NF1	4763	ENSG00000196712,ENST00000358273;;;ENST00000358273		Neurofibromatosis, familial spinal	162210	Autosomal dominant	3	Nf1
17q11.2	17:31094927-31377677	NF1, VRNF, WSS, NFNS	Neurofibromin (neurofibromatosis, type I)	613113	NF1	4763	ENSG00000196712,ENST00000358273;;;ENST00000358273		Neurofibromatosis, type 1	162200	Autosomal dominant	3	Nf1
17q11.2	17:31094927-31377677	NF1, VRNF, WSS, NFNS	Neurofibromin (neurofibromatosis, type I)	613113	NF1	4763	ENSG00000196712,ENST00000358273;;;ENST00000358273		Neurofibromatosis-Noonan syndrome	601321	Autosomal dominant	3	Nf1
17q11.2	17:31094927-31377677	NF1, VRNF, WSS, NFNS	Neurofibromin (neurofibromatosis, type I)	613113	NF1	4763	ENSG00000196712,ENST00000358273;;;ENST00000358273		Watson syndrome	193520	Autosomal dominant	3	Nf1
17q12	17:35092221-35119860	RAD51D, RAD51L3, BROVCA4	RAD51 paralog D	602954	RAD51D	5892	ENSG00000185379,ENST00000345365;;;ENST00000345365		{Breast-ovarian cancer, familial, susceptibility to, 4}	614291		3	Rad51d
17q12	17:39688094-39728658	ERBB2, NGL, NEU, HER2, VSCN2	Avian erythroblastic leukemia viral (v-erb-b2) oncogene homolog 2 (neuro/glioblastoma derived oncogene homolog)	164870	ERBB2	2064	ENSG00000141736,ENST00000269571;;;ENST00000269571	mutation identified in 1 VSCN2 family	?Visceral neuropathy, familial, 2, autosomal recessive	619465	Autosomal recessive	3	Erbb2
17q12	17:39688094-39728658	ERBB2, NGL, NEU, HER2, VSCN2	Avian erythroblastic leukemia viral (v-erb-b2) oncogene homolog 2 (neuro/glioblastoma derived oncogene homolog)	164870	ERBB2	2064	ENSG00000141736,ENST00000269571;;;ENST00000269571	mutation identified in 1 VSCN2 family	Adenocarcinoma of lung, somatic	211980		3	Erbb2
17q12	17:39688094-39728658	ERBB2, NGL, NEU, HER2, VSCN2	Avian erythroblastic leukemia viral (v-erb-b2) oncogene homolog 2 (neuro/glioblastoma derived oncogene homolog)	164870	ERBB2	2064	ENSG00000141736,ENST00000269571;;;ENST00000269571	mutation identified in 1 VSCN2 family	Gastric cancer, somatic	613659		3	Erbb2
17q12	17:39688094-39728658	ERBB2, NGL, NEU, HER2, VSCN2	Avian erythroblastic leukemia viral (v-erb-b2) oncogene homolog 2 (neuro/glioblastoma derived oncogene homolog)	164870	ERBB2	2064	ENSG00000141736,ENST00000269571;;;ENST00000269571	mutation identified in 1 VSCN2 family	Glioblastoma, somatic	137800		3	Erbb2
17q12	17:39688094-39728658	ERBB2, NGL, NEU, HER2, VSCN2	Avian erythroblastic leukemia viral (v-erb-b2) oncogene homolog 2 (neuro/glioblastoma derived oncogene homolog)	164870	ERBB2	2064	ENSG00000141736,ENST00000269571;;;ENST00000269571	mutation identified in 1 VSCN2 family	Ovarian cancer, somatic	167000		3	Erbb2
17q21.2	17:40624962-40647818	SMARCE1, BAF57, CSS5	SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily E, member 1	603111	SMARCE1	6605	ENSG00000073584,ENST00000348513;;;ENST00000348513		Coffin-Siris syndrome 5	616938	Autosomal dominant	3	Smarce1
17q21.2	17:40624962-40647818	SMARCE1, BAF57, CSS5	SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily E, member 1	603111	SMARCE1	6605	ENSG00000073584,ENST00000348513;;;ENST00000348513		{Meningioma, familial, susceptibility to}	607174	Autosomal dominant	3	Smarce1
17q21.31	17:43044295-43170327	BRCA1, PSCP, BROVCA1, PNCA4, FANCS	BRCA1 DNA repair-associated protein	113705	BRCA1	672	ENSG00000012048,ENST00000357654;;;ENST00000357654		Fanconi anemia, complementation group S	617883	Autosomal recessive	3	Brca1
17q21.31	17:43044295-43170327	BRCA1, PSCP, BROVCA1, PNCA4, FANCS	BRCA1 DNA repair-associated protein	113705	BRCA1	672	ENSG00000012048,ENST00000357654;;;ENST00000357654		{Breast-ovarian cancer, familial, 1}	604370	Autosomal dominant; Multifactorial	3	Brca1
17q21.31	17:43044295-43170327	BRCA1, PSCP, BROVCA1, PNCA4, FANCS	BRCA1 DNA repair-associated protein	113705	BRCA1	672	ENSG00000012048,ENST00000357654;;;ENST00000357654		{Pancreatic cancer, susceptibility to, 4}	614320		3	Brca1
17q21.32	17:47189433-47227650	MYL4	Myosin, light polypeptide-4, alkali, atrial, embryonic	160770	MYL4	4635	ENSG00000198336,ENST00000393450;;;ENST00000393450	mutation identified in 1 ATFB18 family	?Atrial fibrillation, familial, 18	617280	Autosomal dominant	3	Myl4
17q22	17:58692573-58735611	RAD51C, FANCO, BROVCA3	RAD52 paralog C	602774	RAD51C	5889	ENSG00000108384,ENST00000337432;;;ENST00000337432		Fanconi anemia, complementation group O	613390	Autosomal recessive	3	Rad51c
17q22	17:58692573-58735611	RAD51C, FANCO, BROVCA3	RAD52 paralog C	602774	RAD51C	5889	ENSG00000108384,ENST00000337432;;;ENST00000337432		{Breast-ovarian cancer, familial, susceptibility to, 3}	613399		3	Rad51c
17q24.3	17:70169532-70180044	KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9	Potassium channel, inwardly rectifying, subfamily J, member 2	600681	KCNJ2	3759	ENSG00000123700,ENST00000243457;;;ENST00000243457		Andersen syndrome	170390	Autosomal dominant	3	Kcnj2
17q24.3	17:70169532-70180044	KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9	Potassium channel, inwardly rectifying, subfamily J, member 2	600681	KCNJ2	3759	ENSG00000123700,ENST00000243457;;;ENST00000243457		Atrial fibrillation, familial, 9	613980	Autosomal dominant	3	Kcnj2
17q24.3	17:70169532-70180044	KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9	Potassium channel, inwardly rectifying, subfamily J, member 2	600681	KCNJ2	3759	ENSG00000123700,ENST00000243457;;;ENST00000243457		Short QT syndrome 3	609622		3	Kcnj2
17q25.1	17:75827225-75844404	UNC13D, MUNC13-4, HPLH3, HLH3, FHL3	unc-13 homolog D	608897	UNC13D	201294	ENSG00000092929,ENST00000207549;;;ENST00000207549		Hemophagocytic lymphohistiocytosis, familial, 3	608898	Autosomal recessive	3	Unc13d
17q25.3	17:82239019-82273750	CSNK1D, ASPS, FASPS2	Casein kinase-1, delta	600864	CSNK1D	1453	ENSG00000141551,ENST00000314028;;;ENST00000314028		Advanced sleep-phase syndrome, familial, 2	615224	Autosomal dominant	3	Csnk1d



Phenotype Mapping Key
1 - The disorder is placed on the map due to its association with a gene, but the underlying defect is not known.
2 - The disorder was placed on the map by statistical methods.
3 - The molecular basis of the disorder is known.
4 - A contiguous gene duplication or deletion syndrome in which multiple genes are involved.



This search returned 238 entries which exceeded the maximum of 200 so the results were truncated
You can register for MIMmatch ( https:///mimmatch/ ) to raise this limit to 1,000
You can register for downloads ( https:///downloads ) and/or the API ( https:///api ) for more search/download options





